Home Blog Page 126

Technological Innovations, Artificial Intelligence Required to Grow Pharma Sector – Prof. Esimone

1

The Federal Government has been urged to show readiness to boost the pharmaceutical sector, by providing adequate funding for further education and technological advancements.

The call was made by Prof. Charles Okechukwu Esimone, eminent professor of Pharmaceutical Microbiology and Biopharmaceutics and vice- chancellor, Nnamdi Azikiwe University, Awka, Anambra State.

Esimone, a Fellow of the Pharmaceutical Society  of Nigeria (PSN) and the Nigeria Academy of Pharmacy, was the keynote speaker at the opening ceremony of the 93rd Annual National Conference of the PSN, tagged “Omoluabi 2020” and held at the De-Distinguished Event Centre, Osogbo, Osun State. He noted that innovation is an inexhaustible engine for economic development.

While speaking on the topic “Technological Revolution: Adaptation in Pharmaceutical Manufacturing, Pharmacy Practice and Regulation”, Esimone disclosed that the country is presently faced with crippling  industrial actions, intractable insecurity, hikes in the prices of food items, galloping inflation and tumbling oil price, all of which he said drive the government and institutions dangerously close to their yield points, saying to overcome the challenges, the country must turn to technology.

Prof. Charles Esimone Emerges New UNIZIK Vice-Chancellor
Professor Charles Okechukwu Esimone

Speaking further, Esimone noted that technological revolution is essential, as technological progress and innovation often cause abrupt changes in the society, adding that a new idea is made practical using technology to solve human problems.

He added, “We must therefore key into the giant technological revolution, which is shaping every facet of the global landscape, and which will exacerbate the gaps between the developing and developed countries. We cannot afford to be left behind.”

He also emphasised that technological innovation could help change the pharmaceutical sector, make global pharma production stronger and bring positive revolutions to pharmaceutical manufacturing and pharmacy practice.

The university don, while harping on the importance of artificial intelligence to the pharmaceutical sector, noted that it thrives heavily on research and development, adding that it is highly regulated like the arms industry and thus necessitating protection of trade secrets and intellectual property, in order to safeguard innovations.

He added, “AI, used in research and development, will enhance the identification of life-saving drugs, reduce design time as well as time required for lead optimisation, reduce the time for clinical trials, improve quality control measures and predictive maintenance accuracy. These will invariably cause a lot of displacement in human labour engagements, with a few machines doing what many humans were hitherto trained and hired to do.”

Esimone further noted that AI can help with customer and product segregation, supplier segregation, digital pills, telepharmacy and virtual pharmacies, saying it is impossible to regulate an advanced product with an obsolete technology.

“How would you regulate a digital pill if you do not have human and equipment capacity? How would you regulate a robotic pharmacist? So, you need expertise in technology, and the time to join is now,” he added.

Allow Girls their Right of Place, UN Urges Global Community

1

To celebrate the international day of zero tolerance for female genital mutilation (FGM) which comes up every February 6, the United Nations (UN) has called on the global community to reimagine a world that enable girls and women to have voice, choice and control over their own lives.

UN says systematic efforts are needed in order to promote the elimination of female genital mutilation, adding that the whole communities must be sensitized on how to focus on human rights, gender equality, sexual education and also must attend to the needs of women who suffer from its consequences.

Allow Girls their Right of Place, UN Urges Global Community
Allow Girls their Right of Place, UN Urges Global Community

FGM comprises all procedures that involve altering or injuring the female genitalia for non-medical reasons and is recognized internationally as a violation of the human rights, the health and the integrity of girls and women.

The intergovernmental organization also noted that girls who undergo female genital mutilation face short-term complications such as severe pain, shock, excessive bleeding, infections, and difficulty in passing urine, as well as long-term consequences for their sexual and reproductive health and mental health.

This year, “No time for global inaction, unite, fund, and act to end female genital mutilation” is the theme and it acknowledges the long-term risks include chronic genital, reproductive health and urinary infections, menstrual problems, infertility, and obstetric complications.

In countries affected by this practice, seven out of ten girls and women feel that FGM should be abandoned.

UN Secretary-General Antonio Guterres said: “Together, we can eliminate female genital mutilation by 2030. Doing so will have a positive ripple effect on the health, education and economic advancement of girls and women.”

The United Nations Population Fund, formerly the United Nations Fund for Population Activities, is a UN agency aimed at improving reproductive and maternal health worldwide. UNFPA gave some facts on Female Genital Mutilation.

  • UNFPA estimates there may be as many as 2 million cases of female genital mutilation by 2030 that would have otherwise been averted due to the COVID-19 pandemic.
  • In 2021 alone, there are 4.16 million girls around the world, who are at risk of undergoing female genital mutilation.
  • According to a UNFPA (pre-COVID-19) study, the cost of preventing female genital mutilation is $95 per girl today.
  • 30 countries where female genital mutilation is prevalent are experiencing high population growth, with at least 30 per cent of girls undergoing female population under the age of 15.
  • Around 1 in 4 girls and women, or 52 million worldwide, experienced female genital mutilation, performed by health personnel pointing to an alarming trend in the medicalization of female genital mutilation.

 

 

 

 

 

Isa Marte Hussaini Becomes Borno State New Commissioner for Health

1
Combating Cancer
Prof. Isa Marte Hussaini

Isa Marte Hussaini, a professor of Pharmacology and Fellow of the Nigeria Academy of Pharmacy (NAPharm), has been appointed as the new commissioner for health by the Borno State government.

His appointment was announced on Tuesday by the Special Adviser on Public Relations and Strategy, Malam Isa Gusau, following the termination of appointment of the former health commissioner, Dr Salisu Kwaya-bura, by the governor.

The Borno State Governor, Prof. Babagana Zulum named Prof. Isa Marte, his chief of staff, as the new officer-in charge of the state health ministry, to replace Dr Salisu Kwaya-Bura.

The appointment was announced in a statement by the Special Adviser on Public Relations and Strategy, Malam Isa Gusau.

The statement reads partly, “The Borno State Governor, Prof. Babagana Zulum, has relieved the state Commissioner for Health, Dr Salisu Kwaya-bura, of his position and named Prof. Hussaini as replacement”.

Gusau had said the directive was part of necessary measures to reposition the ministry of health.

As an erudite scholar and researcher, Prof. Hussaini has been at the forefront in the search and investigation of useful local medical plants for cancer treatment. In 2015, he presented one of his latest research findings to the Nigerian Academy of Science at the induction ceremony of Fellows in Abuja where he stated that some Nigerian herbal plants are more efficacious than the current drugs used in cancer treatments.

Similarly, on 12 February 2016, he presented a lecture, titled “Exploitation of medicinal plant compounds in the search for novel cancer therapeutic agents” in an event hosted by Professor Louise Serpell through the Sussex Nigerian Society, University of Sussex Genome Damage and Stability Centre, UK.

For his outstanding contributions to cancer research in Nigeria, Prof. Hussaini was made a Fellow of Nigeria Academy of Science in 2013 and in November 2015, he was made a Fellow of Nigeria Academy of Pharmacy. He became a Fellow of the Pharmaceutical Society of Nigeria in 2016. He is also a founding member of the International Society of Neuro-Oncology (SNO).

The renowned scholar has, to his credit, 105 peer-reviewed journal publications and five book chapters which have been cited over 3,200 times by other researchers worldwide. Prof. Hussaini has spoken at over 20 international conferences and symposia and he has been invited as a guest lecturer in many universities throughout the world.

 

GlaxoSmithKline Teams up With CureVac to Develop Vaccine For Variants

1

They plan to combine their “scientific expertise in mRNA and vaccine development to advance and accelerate the development of new COVID-19 vaccine candidates.”

British pharmaceuticals company GlaxoSmithKline and German vaccine developer CureVac announced a collaboration on Wednesday to create next generation COVID-19 vaccines to combat emerging variants of the coronavirus.

“We believe that next generation vaccines will be crucial in the continued fight against COVID-19,’’ GSK chief executive Emma Walmsley said, noting that the joint venture builds on an existing partnership between the two companies.

They plan to combine their “scientific expertise in mRNA and vaccine development to advance and accelerate the development of new COVID-19 vaccine candidates,’’ Mr Walmsley said.

In addition, GSK is to support CureVac in producing its first generation vaccines with the manufacture of 100 million doses in 2021, according to a joint statement.

CureVac’s current COVID-19 vaccine is in phase 2b/3 of its clinical testing and could be submitted to regulators for approval in a matter of months.

As part of the collaboration, GSK is to make an upfront payment of 75 million euros (90 million dollars) and a further milestone payment of 75 million euros, “conditional on the achievement of specific milestones,’’ the statement said.

(NAN)

Overcoming Leprosy More Than Early Diagnosis, Prompt Treatment – WHO

2

Yohei Sasakawa, the World Health Organisation (WHO) Goodwill Ambassador for Leprosy Elimination, says overcoming leprosy involves more than early diagnosis and prompt treatment.

Mr Sasakawa stated this in his message to mark the World Leprosy Day posted on the WHO website.

The World Leprosy Day is observed internationally every year on the last Sunday of each January to increase the public awareness of Leprosy or Hansen’s Disease.

Mr Sasakawa said overcoming leprosy also required changing mindsets so that the disease would no longer be a source of shame or prejudice.

“We must remove all barriers in the way of those seeking medical care.

“We must eliminate the obstacles that prevent affected individuals and their families from living in dignity and enjoying all their basic human rights as full members of society.

“I often talk about leprosy in terms of a motorcycle. The front wheel represents curing the disease and the rear wheel symbolises ending discrimination.

“Only when both wheels are turning at the same time will we make progress toward our destination of a leprosy-free world,’’ he said.

According to him, over the past year, the headlines have been dominated by COVID-19.

The ambassador said it was easy to overlook other diseases, especially a disease such as leprosy that many people think is a disease of the past.

“But leprosy requires our attention. There are still some 200,000 new cases diagnosed worldwide each year. Millions of people are living with some form of disability as a result of leprosy.

“Both the label ‘leprosy’ and the disability that can result if this age-old disease goes untreated can lead to social exclusion.

“Persons affected by leprosy continue to face discrimination, reinforced in some countries by outdated laws that make leprosy grounds for divorce, prevent people with the disease from participating in public life or place other restrictions on their activities,’’ he said.

As WHO Goodwill Ambassador for Leprosy Elimination, Mr Sasakawa said he had seen how leprosy has marginalised individuals.

“Women and children are particularly vulnerable to the social and economic consequences of the disease.

“I am confident we are moving in the right direction: the WHO’s Global Leprosy Strategy for 2021-2030 will generate renewed momentum.’’

He said organisations of persons affected by leprosy were becoming more influential and their calls for change more powerful.

“The UN Special Rapporteur on leprosy is working tirelessly to see that principles and guidelines on the elimination of discrimination against persons affected by leprosy and their family members are fully implemented.

“I believe we will achieve a world without leprosy one day.’’

Cervical Cancer: WHO Partners NPHCDA to Introduce HPV Vaccine in Nigeria

3

World Health Organisation Country Representative to Nigeria, Walter Mulombo, says the organisation is working with National Primary Health Care Development Agency to introduce Human papillomavirus vaccine into Expanded Programme on Immunisation schedule.

The information is in Mulombo’s message to mark the World Cancer Day on Thursday in Abuja.

World Cancer Day is an international day marked on Feb. 4 to raise awareness of cancer and to encourage its prevention, detection, and treatment.

According to him, HPV vaccine is key to preventing cervical cancer, noting that so far, 17 African countries have introduced HPV vaccination nationwide.

He said some countries were achieving high national HPV vaccine coverage with the commitment of their governments and partners.

Female Gynecologist During Examination In Her Office.

He noted that WHO had been recommending comprehensive approach to cancer control in its support on prevention and management of cancer in Nigeria.

He added that “WHO recommends comprehensive approach to cancer control, which spans prevention, early detection, diagnosis, treatment and palliative care.

“Prevention is undertaken through cancer behavioural causes: tobacco, overweight, physical activity, and harmful use of alcohol.

“These risk factors are on the rise in Africa and WHO supports member states to develop and implement Non-Communicable Diseases (NCDs) Global Action plan.

“With WHO’s support, Nigeria developed its 2019-2025 NCDs Multisectoral Action Plan which highlights various interventions to reduce the burden of NCDs in the country.

“WHO also supported government of Nigeria to develop the National Cancer Plan which highlights various interventions to reduce the burden of cancer in the country.’’

In addition, the country representative said, WHO had been supporting the development of National Strategic Plan on prevention and control of cervical cancer (2017 – 2021).

“It has also supported the development of an annual implementation plan (2020-2021) and Monitoring and Evaluation framework for cervical cancer control and prevention.’’

Mulombo, however, appreciated the efforts that Government (at national and state levels) and partners who were implementing interventions to prevent and control cancer and its risk factors in Nigeria.

He said WHO was committed to supporting Federal Government in the fight against non-communicable diseases, cancer in particular.

“I would like to urge partners and government to sustain the efforts and commit more resources to accelerate actions to prevent and reduce cancer in Nigeria,’’ the official said.

According to him, WHO joins the international community in commemorating the 2021 World Cancer Day under the theme “I am and I will” to mark the end of the three-year campaign.

He explained that the campaign tagged “I am and I will” sought to reduce fear, increase understanding and change behaviours and attitude around cancer.

He added that “over the past 20 years, new cancer cases have more than doubled in the African Region from 338,000 cases reported in 2002 to almost 846,000 cases in 2020.

“The most common forms are cancers of the breast, cervix, prostate, bowel, colon, rectum and liver.’’

(NAN)

World Cancer Day 2021: Breast Cancer Leads Among Others

0

In a bid to reduce the worldwide burden of the disease called cancer, which not only has killed about thrice the number of people who have died of tuberculosis, HIV and malaria combined; World Cancer Day (WCD) was established in 2008.

In commemorating the 2021 World Cancer Day, the World Health Organisation,WHO, has identified breast cancer as the most common of all cancers in the world.

Andre Ilbawi, a cancer specialist at the WHO, said breast cancer has overtaken lung cancer as the most common form of the disease, adding that for the first time, breast cancer now constitutes the most commonly occurring cancer globally.

The Union for International Cancer Control (UICC), established the World Cancer Day (WCD), on 4 February, 2008, to raise awareness and generate support for people living with the disease.

From then on, WCD has been commemorated annually. However, the impact of the celebration seems quite limited, as the prevalence of the terminal disease continues to rise from year to year, and from border to border, claiming multitudes of lives all along.

This year, “I am and I will” is the theme and it acknowledges that everyone has the capacity to act in the face of cancer.

According to WHO, one major issue that has been generally identified as a setback in the fight against cancer, is inadequate medical facilities for the screening and treatment of the condition, as well as late presentation of patients to care centres.

A WHO survey conducted in 2020 indicated that treatment for cancer had been disrupted in more than 40 per cent of countries surveyed during the pandemic.

According to the findings published on their website, it indicates that delays in diagnosis are common, while interruptions to and abandonment of therapy have increased significantly. Meanwhile, enrolment in clinical trials and research output have declined.

The health organization said cancer is the leading cause of death for children and adolescents, with an estimated 400 000 children diagnosed with cancer each year.

The agency added that on International Childhood Cancer Day, 15 February, they will be releasing a “how-to” guide for policy-makers and programme managers on strengthening childhood cancer programmes; a new assessment tool to facilitate harmonized data collection and to enable expedited, real-time interpretation of collected data on cancer among children; and an online community-of-practice information-sharing hub for childhood cancer.

“Breast, cervical and childhood cancers all have a high chance of cure if diagnosed early and treated appropriately,” WHO said.

Andre Ilbawi noted that lung cancer was the most common type for the last two decades, but is now in second place, ahead of colorectal cancer, which is the third most widespread.

He also said obesity in women was a common risk factor in breast cancer, and is also driving overall cancer numbers.

As the global population grows and life expectancy increases, cancer is expected to become more common, rising to about 30 million new cases per year in 2040 from 19.3 million in 2020, Ilbawi said.

The coronavirus pandemic is disrupting cancer treatment in about half the countries it surveyed, Ilbawi said, pointing to delays in diagnosis, healthcare workers being under extreme stress and research being impacted.

COVAX Releases List of COVID-19 Vaccine Recipients, Gives Nigeria 16m Doses

0
  • India tops list
  • First deliveries expected late February

The COVAX programme to ensure equitable worldwide access to COVID-19 vaccines on Wednesday published its first distribution list, with enough doses for countries to immunise more than three percent of their populations by mid-2021.

The distribution plan comes with lower-income countries falling behind in the vaccination race — a problem COVAX was set up to address.

It broke down how the programme’s initial 337.2 million doses will be distributed, with first deliveries expected in late February.

Covid-19: EU Secures Additional 300 Million Doses of Pfizer Vaccine
COVID-19 Vaccine

Some 145 countries are set to receive enough doses to immunise 3.3 percent of their collective population by mid-2021, COVAX said.

A statement said the initial distribution was in line with a target “to protect the most vulnerable groups such as health care workers” in the first half of the year.

“Soon we’ll be able to start delivering life-saving vaccines globally — an outcome we know is essential if we’re to have any chance of being able to beat this pandemic,” Gavi chief executive Seth Berkeley told a news conference.

COVAX is co-led by the World Health Organization (WHO), the Gavi vaccine alliance, and the Coalition for Epidemic Preparedness Innovations.

India tops list 
Countries will receive doses in proportion to population size, with the most going to India (97.2 million), Pakistan (17.2 million), Nigeria (16 million), Indonesia (13.7 million), Bangladesh (12.8 million) and Brazil (10.6 million).

Other big recipients are Ethiopia (8.9 million), the Democratic Republic of Congo (6.9 million), Mexico (6.5 million), the Philippines (5.6 million) and Egypt (5.1 million).

WHO immunisation programme coordinator Ann Lindstrand said priority was given to countries that had not started vaccinating, while health worker deaths in January were also factored in.

For the 92 lower- and lower-middle income economies involved in COVAX, funding is covered through donations, while for richer countries, buying into bulk purchases operates like a back-up insurance policy for their own vaccination programmes.

The first wave distribution list includes 240 million doses of the AstraZeneca-Oxford vaccine, licensed to the Serum Institute of India; 96 million advance-purchased AstraZeneca-Oxford doses; and 1.2 million doses of the Pfizer-BioNTech vaccine.

Both vaccines require two injected doses.

Pfizer-BioNTech is the only vaccine to have received emergency use approval from the WHO. Evaluation is under way for the AstraZeneca-Oxford vaccine.

Berkeley said though they were “impatient… to get these doses out, there are conditions that must be in place”.

18 countries getting Pfizer
The Pfizer-BioNTech doses — requiring special ultra-cold storage — are destined for 18 countries by the end of March, with Colombia, Peru, the Philippines, South Africa, South Korea and Ukraine getting the most at 117,000 doses each.

The other scheduled recipients are Bhutan, Bolivia, Bosnia and Herzegovina, Cape Verde, El Salvador, Georgia, Maldives, Moldova, Mongolia, the Palestinian Territories, Rwanda and Tunisia.

The first round list, including both vaccine types, is subject to change but should allow countries to plan ahead.

Some wealthy self-financing countries were on the list, including South Korea (2.6 million doses), Canada (1.9 million) and New Zealand (250,000).

Tuvalu is set to receive the smallest number of doses at 4,800, followed by Nauru and Monaco with 7,200 each.

Around 190 countries are involved in COVAX.

Countries unlisted this time have either exercised their rights to opt-out, have not submitted vaccine requests, or have not yet been allocated doses.

The United States under new President Joe Biden recently said it would be taking part in COVAX.

COVAX aims to secure enough vaccines for at least the most vulnerable 20 percent in participating countries by the end of 2021.

(AFP)

United Nations Urges Less Consumption of Meat

1

Eating less meat can help reduce the risk of a pandemic, in addition to saving the environment, the UN Environment Programme said on Wednesday.

The UNEP said this while announcing a new Chatham House report.

“At a time when so much of the world continues to battle the COVID-19 pandemic, it’s never been more obvious that the well-being of people and animals, wild and farmed, are intertwined,” said Philip Lymbery, of Compassion in World Farming, which also backed the think tank.

If ecosystems continue to be destroyed, the population’s food supply will be at risk, they warned.

A move towards more plant-based foods are necessary to ensure biodiversity loss will not accelerate, they add.

In addition, more land needs to be protected, and agriculture needs to become more environmentally friendly, they said.

Natural ecosystems have been increasingly converted into arable land and pasture in recent decades, leading to loss of animal habitats.

“The intensive farming of billions of animals globally seriously damages the environment, causing loss of biodiversity and producing massive greenhouse gas emissions that accelerate global warming,” said famed primatologist Jane Goodall in the UNEP statement.

(dpa/NAN)

All of the following are normally involved in the pathogenesis of heart failure EXCEPT:

28

All of the following are normally involved in the pathogenesis of heart failure EXCEPT:

a) A cardiac lesion that impairs cardiac output

b) An increase in peripheral vascular resistance

c) A decrease in preload

d) An increase in sodium and water retention

Ebonyi Agog as NAIP, Bloom Public Health Unveil Pharmacity

9

-Ohuabunwa, Anukwu, Anyakora Laud State Govt at Ground-breaking Ceremony

It was an epoch event on Wednesday 3 February, 2021 in Ebonyi State, South East Nigeria as the Association of Industrial Pharmacists of Nigeria (NAIP), in conjunction with Bloom Public Health unveiled the premier pharmaceutical manufacturing park in West Africa. Located in the Ntezi community of Ebonyi State and occupying a one hundred hectares of land, the pharmaceutical manufacturing park will be the hub for quality medicine production in the whole of West Africa.

While performing the ground-breaking ceremony for the project also known as Pharmacity, Ebonyi State Governor, Engineer David Umahi, pledged his government’s support for the project and promised to do all within his capacity to ensure that the park is fully actualized.

R-L: Mazi Sam Ohuabunwa, PSN president; Engr. David Umahi, executive governor of Ebonyi State; Pharm. IG Anukwu, chairman of NAIP and Prof. Chimezie Anyakora, CEO, Bloom Public Health, at the unveiling of the Pharmacity project in Ebonyi State.

Also speaking at the well-attended event, President of the Pharmaceutical Society of Nigeria, Mazi Sam Ohuabunwa, expressed immense joy for the unveiling of the project. He also thankfully assured the Ebonyi State government of his association’s commitment towards ensuring that the project comes to total fruition.

On his part, National Chairman of the Association of Industrial Pharmacists of Nigeria, Pharm. Ignatius Anukwu, expressed profound satisfaction with the outcome of the journey which, according to him, took over one year of negotiations to materialize.

In his remarks, eminent Professor of Pharmaceutical Chemistry and CEO, Bloom Public Health, Chimezie Anyakora, informed the governor that the journey is anything but over and that the commitment of all stakeholders is needed to cross the finish line. He also reminded the community of the immense value and benefits that await them when the park begins operations, adding that the Ntezi Community would soon become a well-known name.

 

15 Ways to Lower Your Blood Pressure Naturally, According to Experts

2
15 Ways to Lower Your Blood Pressure Naturally, According to Experts
Different natural fruits on display for lowering high blood pressure

When you get a high blood pressure reading at the doctor’s office, it might be tough for you to understand exactly what impact those numbers can make on your overall health. After all, high blood pressure (a.k.a. hypertension) has no unusual day-to-day symptoms.

But the truth is that having high blood pressure is a serious health risk—it boosts the chances of leading killers such as heart attack and stroke, as well as aneurysms, cognitive decline, and kidney failure. What’s more, high blood pressure was a primary or contributing cause of death for nearly 500,000 people in 2018, per the latest data from the Centers for Disease Control and Prevention (CDC)

Even scarier? One in five U.S. adults with high blood pressure don’t know they have it, per the CDC. If you haven’t had your numbers checked in at least two years, see a doctor. Anything above 130/80 mmHg is considered high. (Systolic blood pressure is the top number; diastolic, the bottom.)

Although medication can lower blood pressure, it may cause side effects such as leg cramps, dizziness, and insomnia. The good news is that most people can bring their numbers down naturally, without using drugs. “Lifestyle changes are an important part of prevention and treatment of high blood pressure,” says Brandie D. Williams, M.D., a cardiologist at Texas Health Stephenville and Texas Health Physicians Group.

You’ve quit smoking. You’re paying attention to your weight. Now, try these natural ways to lower your blood pressure—no pills necessary.

  1. Get more exercise.

Regular exercise, even as simple as walking, seems to be just as effective at lowering blood pressure as commonly used BP drugs, according to a 2018 meta-analysis of hundreds of studies. Exercise strengthens the heart, meaning it doesn’t have to work as hard to pump blood. Dr. Williams recommends shooting for 30 minutes of cardio on most days. Over time, you can keep challenging your ticker by increasing speed, upping distance, or adding weights. Losing even a little weight will also help ease hypertension.

  1. Let yourself relax.

Our bodies react to stress by releasing hormones like cortisol and adrenaline. These hormones can raise your heart rate and constrict blood vessels, causing your blood pressure to spike. But breathing exercises and practices like meditation, yoga, and tai chi can help keep stress hormones—and your blood pressure—in check, Dr. Williams says. Start with five minutes of calming breathing or mindfulness in the morning and five minutes at night, then build up from there.

  1. Cut down on salt.

Although not everyone’s blood pressure is particularly salt-sensitive, everyone could benefit from cutting back, says Eva Obarzanek, Ph.D., research nutritionist at the National Heart, Lung, and Blood Institute. The American Heart Association recommends aiming for 1,500 mg of sodium in a day, and certainly no more than 2,300 mg (about a teaspoon). Obarzanek suggests treading with caution around packaged and processed foods, including secret salt bombs like bread, pizza, poultry, soup, and sandwiches.

  1. Pick potassium-rich foods.

Getting 2,000 to 4,000 mg of potassium a day can help lower blood pressure, says Linda Van Horn, Ph.D., R.D., a professor of preventive medicine at Northwestern University Feinberg School of Medicine. (The nutrient encourages the kidneys to excrete more sodium through urination.) We all know about the potassium in bananas, but foods like potatoes, spinach, and beans actually pack more potassium than the fruit. Tomatoes, avocados, edamame, watermelon, and dried fruits are other great sources.

  1. Adopt the DASH diet.

Alongside the Mediterranean diet, the Dietary Approaches to Stop Hypertension (DASH) diet is consistently ranked as one of the absolute healthiest eating plans—and it was developed specifically to lower blood pressure without medication. The diet emphasizes veggies, fruits, whole grains, lean proteins, and low-fat dairy, capping daily sodium intake at 2,300 mg, with an ideal limit at that all-important 1,500 mg. Research shows DASH can reduce BP in just four weeks and even aid weight loss.

  1. Indulge in dark chocolate.

The sweet is rich in flavanols, which relax blood vessels and boost blood flow, and research suggests that regular dark chocolate consumption could lower your blood pressure. Experts haven’t determined an ideal percentage of cocoa, says Vivian Mo, M.D., clinical associate professor of medicine at the University of Southern California, but the higher you go, the more benefits you’ll get. Chocolate can’t be your main strategy for managing blood pressure, Mo says—but when you’re craving a treat, it’s a healthy choice.

  1. Drink wisely.

Too much booze is known to raise blood pressure—but having just a little bit could do the opposite. Light-to-moderate drinking (one drink or fewer per day) is associated with a lower risk for hypertension in women, per a study following nearly 30,000 women. One drink means 12 ounces of beer, 5 ounces of wine, or 1.5 ounces of spirits. “High levels of alcohol are clearly detrimental,” Obarzanek says, “but moderate alcohol is protective of the heart. If you are going to drink, drink moderately.”

  1. Switch to decaf.

A 2016 meta-analysis of 34 studies revealed that the amount of caffeine in one or two cups of coffee raises both systolic and diastolic blood pressure for up to three hours, tightening blood vessels and magnifying the effects of stress. “When you’re under stress, your heart starts pumping a lot more blood, boosting blood pressure,” says James Lane, Ph.D., a Duke University researcher who studies caffeine and cardiovascular health. “And caffeine exaggerates that effect.” Decaf has the same flavor without the side effects.

  1. Take up tea.

It turns out that lowering high blood pressure is as easy as one, two, tea. Adults with mildly high blood pressure who sipped three cups of naturally caffeine-free hibiscus tea daily lowered their systolic BP by seven points in six weeks, a 2009 study reported. And a 2014 meta-analysis found that consuming both caffeinated and decaf green tea is associated with significantly lowering BP over time. Tea’s polyphenols and phytochemicals (nutrients found only in fruits and veggies) could be behind its benefits.

  1. Work less.

Putting in more than 40 hours per week at the office raises your risk of hypertension by 17%, according to a study of more than 24,000 California residents. Working overtime takes away time for exercise and healthy cooking, says Haiou Yang, Ph.D., the study’s lead researcher. Not everyone can clock out early, but if you work a 9 to 5, try to log off at a decent hour so you can work out, cook, and relax. (To get in this habit, set an end-of-day reminder on your work computer and peace out as soon as you can.)

  1. Sit less, too.

In the age of working from home, it’s easier than ever to accidentally sit at your desk all day. Study after study after study has shown that interrupting prolonged sitting time at work can reduce hypertension, working in tandem with other practices like exercising, eating well, and getting enough sleep. Simply get up for a bit every 20 to 30 minutes, and at least every hour—even non-exercise activities like standing and light walking really can lower BP over time, especially if you start to sit less and less.

  1. Relax with music.

The right tunes (and a few deep breaths) can help bring your blood pressure down, according to research out of Italy. Researchers asked 29 adults who were already taking BP medication to listen to soothing classical, Celtic, or Indian music for 30 minutes daily while breathing slowly. When they followed up with the subjects six months later, their blood pressure had dropped significantly. Louder, faster music probably won’t do the trick, but there’s no harm in blissing out to an ambient track or two.

  1. Try fermented foods.

A 2020 meta-analysis of over 2,000 patients found that eating fermented foods—specifically supplements made from fermented milk—was associated with a moderate reduction in blood pressure in the short term. The culprit could be the bacteria living in these foods, which might produce certain chemicals that lower hypertension when they reach the blood. Other fermented foods, including kimchi, kombucha, and sauerkraut, haven’t been studied in the same way, but they probably can’t hurt.

  1. Seek help for snoring.

Loud, incessant snoring is a symptom of obstructive sleep apnea (OSA), a disorder that causes brief but dangerous breathing interruptions. Up to half of sleep apnea patients also live with hypertension, possibly due to high levels of aldosterone, a hormone that can boost blood pressure. Fixing sleep apnea could be helpful for improving BP, says Robert Greenfield, M.D., medical director of Non-Invasive Cardiology & Cardiac Rehabilitation at MemorialCare Heart & Vascular Institute.

  1. Focus on protein

Replacing refined carbohydrates (like white flour and sweets) with foods high in soy or milk protein (like tofu and low-fat dairy) can bring down systolic blood pressure in those with hypertension, findings suggest. “Some patients get inflammation from refined carbohydrates,” says Matthew J. Budoff, M.D., F.A.C.C., professor of medicine at the David Geffen School of Medicine and director of cardiac CT at the Division of Cardiology at the Harbor-UCLA Medical Center, “which will increase blood pressure.”

 

 

Prevention.com

Epidemiologist Urges Research Into Suspected COVID-19-Induced Blindness

2

A recent case, seen by doctors in the United Kingdom, of an individual experiencing persistent blindness due to Coronavirus-related complications is, so far, an isolated one, although further research will be required, an official said.

Natalya Pshenichnaya, an epidemiologist at Russia’s consumer watchdog Rospotrebnadzor, said this on Tuesday.

Physicians in the UK published their findings in the Cureus journal on Jan. 19.

They described a 54-year-old woman who experienced persistent cortical blindness after undergoing intensive care treatment for posterior reversible encephalopathy syndrome and severe COVID-19 symptoms.

“An almost isolated case of cortical blindness was recently outlined by British doctors.

“Since this case, at least for now, is unique, it is impossible to draw any conclusions about the causal connection of this symptom with COVID-19,” Pshenichnaya said.

The Rospotrebnadzor epidemiologist said that the woman may have experienced a stroke while undergoing treatment, adding that more research will be required to assess the case in question.

“Neurologists need to study all the circumstances of the patient’s pathological condition in detail,” Pshenichnaya remarked.

Cortical blindness is the partial or total loss of vision caused by damage to the brain’s occipital cortex.

(Sputnik/NAN)

It Seems Hard to Speak and Listen in a Masked World -Researchers

1

A team of researchers from University of California, Davis, have said 14 months into COVID-19 living, people are adapting to speaking from behind, and understanding others who are wearing a cloth face mask.

They added that it has become difficult for people who wear face masks to speak and also to be listened to. However, people are seeming to adapt.

In a bid to advance understanding, the researchers investigated how well speech is understood from those speaking while wearing a cloth mask. Due to social distancing measures, speakers for the study consisted of individuals from the same household, who recorded sentences while face-masked and non-face-masked.

They tested how well a separate group of listeners, 63 individuals at UC Davis, could understand these productions. They discovered that masked speech was a bit difficult to understand.

Michelle Cohn, the study’s lead author said when the speakers were instructed to ‘speak clearly’ while wearing a face-mask, their speech became better understood by listeners.

She added that results from the current study revealed that wearing a fabric face mask does not uniformly affect speech intelligibility across styles, noting that speakers are dynamically assessing listener difficulty and adapting their ‘clear’ speech accordingly.

Another study published in the journal Cognition shows that intelligibility of face-masked speech depends on speaking style: Comparing casual, clear, and emotional speech.

Speakers, who were members of the same household, produced sentences in three speech styles (casual, clear, positive-emotional) while in both masked and unmasked conditions. Audio-recording equipment was mailed to their home.

In the experiment, researchers added background noise to a recording of a variety of sentences being spoken. The ambient noise made it more difficult to understand speakers, mimicking, for example, the circumstances at crowded supermarkets or in public, Cohn said.

These recordings were played to listeners who completed the experiment online. (Listeners were all native speakers of American English recruited from a UC Davis psychology pool.) Their task was to listen carefully to each sentence, and type the last word that they heard.

For example, after hearing the sentence: “Miss Brown might consider the coast,” the participant would type “coast” if they heard the word correctly, or perhaps “toast” if they heard it incorrectly. For “casual” and “smiled” speech, listeners were less able to identify words when the speakers were wearing a fabric face mask, compared to when they were not wearing one, researchers found.

The results showing that most people could, however, adapt their speaking and listening skills can be used to produce practical public recommendations for face-masked speech adaptations in everyday situations. By instructing talkers to “speak clearly” the disadvantages of face-masked speech in noisy conditions can be overcome, researchers said.

Cohn said the results have highlighted the adaptive nature of human speech and helped to understand why it is a successful communication tool, even when situations where listening is hard.

 

1,634 New COVID-19 Cases, Six Deaths Reported Across 25 States, FCT

0
1,634 new COVID-19 cases, six deaths reported across 25 states, FCT
COVID-19 prevention infograph Photo: WHO

The Nigeria Centre for Disease Control has recorded 1,634 new cases of COVID-19, bringing the total number of infections in the country to 133,552.

The NCDC disclosed this on its official Twitter handle on Tuesday.

The News Agency of Nigeria reports that the country has so far tested 1,302,410 people since the first confirmed case of COVID-19 was recorded on February 27, 2020.

The agency also confirmed additional six coronavirus-related deaths in the last 24 hours bringing the death toll to 1,613 in the country.

It noted that the 1,634 new COVID-19 infections were from 25 states and the Federal Capital Territory.

The agency said Lagos state reported the highest number of infections with 440, while Anambra confirmed 160, FCT 158 and Rivers 134.

Amongst other states with new cases were Abia-103, Oyo-90, Enugu-81, Osun-73, HGombe-54, Kwara-50, Ogun-32, Plateau-32, Akwa Ibom-31, Ondo-24, Borno-23, Delta-23, Ebonyi-21, Taraba-21, Bayelsa-16, Kaduna-15, Nasarawa-13, Jigawa-12, Bauchi-11, Kano-11, Zamfara-4 and Sokoto-2.

The NCDC, however, said that the number of recoveries currently stood at 107,551, with additional 1,276 people discharged across the country in the past 24 hours.

It stated that today’s discharge included 551 community recoveries in Lagos State, 213 in Kaduna State and 103 in Kano State managed in line with its guidelines.

The public health agency stated that the country has 24, 388 active cases across 34 states and the FCT.

It noted that only two states – Kogi and Cross River – had no active case of the infection as of February 2.

The agency said a multi-sectoral national Emergency Operations Centre, activated at Level 3, was coordinating response activities nationwide.

Meanwhile, the agency said that the B.1.1.7 variant, first identified in the UK had been identified in six more COVID-19 cases in the country.

“While we strengthen our genomic surveillance capacity with partners to inform our response, non-pharmaceutical interventions remain effective to limit spread.

“Even with the COVID-19 vaccines, the non-pharmaceutical interventions such as the use of face masks, physical distancing etc. remain critical to reducing the spread of the infection,” it advised.

(NAN)

What do you understand by the mechanism of valproate action?

9

The mechanism of valproate action is:

a) Facilitation glutamic acid decarboxylase, the enzyme responsible for GABA synthesis and inhibition of GABAaminotransferase, the enzyme responsible for the breakdown of GABA (enhance GABA accumulation)

b) Inhibition of voltage sensitive Na+ channels

c) Inhibition of low threshold (T-type) Ca2+ channels

d) All of the above

COVID-19: 75 Health Workers Test Positive, Says NCDC DG

2

 

Front-line health workers in the line of duty

As the nation battles the containment of the deadly virus infection, 75 health workers have contracted the infection in the line of duty, says the Nigeria Centre for Disease Control, NCDC.

This comes as the nation recorded its highest deaths of 27 patients in a single day last week.
Speaking on the development, the Director General, NCDC, Dr Chikwe Ihekweazu expressed his grief over the fatality rate, saying each death is tragic occurrence for the agency.

Ihekweazu who made the disclosure in a televised interview on Tuesday advised all health workers to maintain high level of suspicion in the line of duty as every patient is a suspect.

He said: “In the last one week, 75 health care workers were infected, but we can reduce this risk.
“Every death recorded is a tragic occurrence and our health workers are working extremely hard to prevent this.

“For healthcare workers, please maintain a high index of suspicion at all times. We need you alive and well,” the DG noted.

Ihekweazu revealed that the United Kingdom variant of the virus has been discovered in five samples from Osun State and one from Kwara State.

Meanwhile, the Federal Government has placed health workers on priority list of people to receive the COVID-19 vaccine as soon as it arrive the country.

The Executive Director of the National Primary Healthcare Development Agency, Faissal Shuaib, disclosed that Nigeria is expecting 16 million doses of Astrazeneca vaccine this month.

He explained that this would replace the 100,000 Pfizer vaccine earlier being expected.

Shuaib said, “The African Union Commission through the African Vaccine Acquisition Task Team portfolio, has approved approximately 41m doses of a combination of Pfizer/BioNTech, AstraZeneca and Johnson & Johnson COVID-19 vaccines in March/April 2021”.

Borno Health Commissioner Sacked Amidst COVID-19 Pandemic

0

As part of measures to reposition the health ministry in the state, Gov. Babagana Zulum of Borno State has relieved the Commissioner of Health, Dr Salihu Kwaya-Bura of his position.

The directive is contained in a statement by the Special Adviser to the governor on Public Relations and Strategy, Malam Isa Gusau.

”The governor has directed his Chief of Staff, Isa Marte, a Professor of pharmacology and fellow of the Nigerian Academy of Science with a specialty in cancer research, to oversee the affairs of the ministry pending the appointment of a substantive commissioner.

“Zulum expresses gratitude to the sacked commissioner for his immense contributions to the development of Borno public health sector in nearly two years of the current administration and the years he had served under the previous administration,” Gusau said.

More Than 100 Million People Vaccinated Against COVID-19 Globally

0

More than 100 million COVID-19 vaccines have been given around the world, an AFP tally from official sources found on Tuesday.

But none of the world’s 29 poorest countries has formally started mass vaccination drives, while the richest nations have given more than two-thirds of jabs administered.

Israel leads the race by far, with 37 per cent of its population having received at least one dose, while more than a fifth have already got their second.

Yet more than a third of humanity (35 per cent) live in countries where vaccination has yet to begin.

After Israel, the countries that have given the most doses are in North America, Europe and the Persian Gulf.

The UK heads this group in per capita terms with shots given to 13.7 per cent of its people, ahead of the US (32.2 million shots to 7.9 per cent).

The European Union has been clashing bitterly with AstraZeneca over access to supplies of its vaccine, with only 12.7 million shots given to 2.3 per cent of its people.

China, by contrast, has given 24 million shots, while India – where many of the vaccines are made – has given only four million to a tiny percentage of its vast population. 

The EU’s best-performing countries are tiny Malta (5.4 per cent), Denmark (3.2 per cent) and Poland (3.1 per cent). 

The UK’s nearest competitor in Europe is Serbia, which is also outside the bloc.

It has given the Chinese Sinopharm and Russia’s Sputnik V jabs to 6.2 per cent of its population.

With the World Health Organisation lamenting that “rich countries are rolling out vaccines while least-developed countries watch and wait,” 101,317,005 jabs had been given in 77 mostly wealthy countries and territories, AFP’s count found.

Some rich countries, however, have yet to start vaccinating, including Japan, South Korea and Australia, which have managed to contain the pandemic with strict border controls and quarantines.

The first deliveries of the WHO’s Covax scheme to share shots more fairly are due begin this month. So far only Guinea has benefited, with only a few dozen given in a pilot trial.

There are currently seven vaccines circulating around the world, all designed to be given in two doses.

The vaccines developed by Pfizer-BioNTech (US-German) and Moderna (US) are dominant in North America, Europe, Israel and the Gulf.

Britain’s AstraZeneca-Oxford is used in much of the UK and India, Myanmar, Sri Lanka and Morocco, and is soon to be rolled out in Europe. 

India also uses a homegrown vaccine produced by Bharat Biotech.

Russia’s Sputnik V vaccine has been rolled out in Russia, Argentina, Algeria, Belarus and Serbia.

China’s Sinopharm jabs are being administered in China, the United Arab Emirates, Bahrain, Serbia the Seychelles and Jordan, while Indonesia and Turkey are using China’s Sinovac vaccine.

China’s Sinovac and Sinopharm vaccines and Russia’s Sputnik V jab have yet to be fully approved by either Beijing or Moscow’s health authorities.

(AFP)

Deaths of COVID-19 Patients in ICU Have Reduced –Study

0

COVID-19 treatments and improved hospital care have reduced death rates in intensive care by more than a third since the early months of the pandemic, but this progress might be stalling, according to research published on Tuesday.   

Whereas medical staff in the first wave of the epidemic had few insights to help them tackle the new virus, they now have some effective drugs and therapies for treating severely ill patients. 

A large-scale meta-analysis of overall mortality of COVID-19 patients in intensive care units around the world, published in the journal Anaesthesia, found that it had fallen to 36 per cent by October. 

An earlier analysis by the same authors found that ICU mortality had fallen from 60 per cent in late March 2020 to 42 per cent at the end of May.  

“After our first meta-analysis last year showed a large drop in ICU mortality from COVID-19 from March to May 2020, this updated analysis shows that any fall in mortality rate between June and October 2020 appears to have flattened or plateaued,” the authors said. 

Researchers looked at data from 52 observational studies involving 43,128 patients.

The studies were from Europe, North America and China — areas included in the earlier analysis – as well as reports from the Middle East, South Asia and Australia.

The authors said that hospitals now have much more knowledge about what works — and what does not. 

In particular, medics now can use steroids like dexamethasone to improve the survival chances of seriously ill patients on oxygen support. Strategies for oxygen therapy, fluid therapy and management of blood clotting have all evolved since the early days of the pandemic.

But with several new variants of the coronavirus emerging in the months since the end of their analysis, they said ICUs may come under further pressure.   

British scientists recently warned that the variant that emerged there was not only more transmissible but could also be more deadly.

Peter Horby, who leads the Recovery trial that provided the evidence for the use of dexamethasone, said recently however that the drugs should continue to work equally well with the new variants. This is because they act on the body’s immune response, not the virus itself.

Horby, professor of emerging infectious disease at Oxford University, said overall improvements in therapies and treatments have brought down case fatality rates since the first wave and could even “offset any difference with this new variant”. 

(AFP)

What is characteristic of the intramuscular route of drug administration?

25

What is characteristic of the intramuscular route of drug administration?

a) Only water solutions can be injected

b) Oily solutions can be injected

c) Opportunity of hypertonic solution injections

d) The action develops slower, than at oral administration

Unlimited Potentials of Community Pharmacy Practice

1

The year 2020 was one like no other. It was a year that changed our lives completely and gave us something that is now commonly referred to as the “new normal”. We will have cause to discuss the details of the new normal in due course in this new year, 2021.

Glory to God that we survived the year 2020 with all its baggage of COVID-19 pandemic, economic dislocation, and family distress. We can now focus our attention on the brighter future that 2021 offers. It is a time for us to examine our environment for latent opportunities that can be professionally and profitably exploited, starting with community pharmacy practice.

Untapped potentials

Pharmacists represent the third largest healthcare professional group in the world. They are also the most accessible, particularly in the community setting.

The traditional role of pharmacists is to manufacture, store, distribute, and dispense medicines. This role has been expanded to include pharmaceutical care of guiding, counselling the patients and other health workers on the use and administration of medicines. In a developing society like ours, this role can be said to be partially fulfilled because we rely substantially on imported drugs and drug distribution remains largely unsatisfactory.

The hospital system in Nigeria, as at today, has not given room for the concept of pharmaceutical care to be firmly entrenched. It is an undeniable fact that there still exists a huge gap between the training and practice of Pharmacy. This topic was first discussed with the Lagos State branch of ACPN in 2008 and nothing has changed significantly since then, 13 years after! The level of discontent has become so high that many pharmacists, particularly the young ones, look for solace in some other endeavours in IT and other business or entrepreneurial activities.

Dr Lolu Ojo

Changing the narrative

The “low hanging fruit” in changing the narrative for the pharmacy profession in Nigeria lies principally in tapping the potentials of community pharmacy practice. To do this, we must understand the current challenges and use our knowledge and experience to overcome them.

A community pharmacy is set up to perform the following functions, among others: drug procurement, storage and management; patient counselling and guidance; dispensing of prescriptions; patient follow-up; pharmacy administration; compounding; drug information service; documentation; and research.

However, the challenges are many and daunting, ranging from unhealthy and unprofessional competition (from traders and dispensing clinics/hospitals in the community), limited finance and access to fund, to poor sales and return on investment, poor public perception, poor infrastructures, security issues (Nigeria is in trouble generally on this scale), drug procurement issues, continuity issues and lack of professional fulfilment.

The solution to our problems lies with us. We need to change our orientation towards the practice. Individual, corporate or group goals must be clearly defined, and success pathway outlined. The profession must unequivocally dedicate itself to a philosophy that clearly identifies the patient as its primary beneficiary practice.

Professionalism is the number one tool to be deployed in overcoming the challenges identified. The practice must be based, PRINCIPALLY, on the knowledge, skill, expertise, or competence expected of a professional. What truly is the difference between a pharmacist-owned premises and the others? We must put on our “thinking cap” and our “running shoes” and get our customers or clients to know and appreciate the difference.

Everything communicates: From the shop arrangement, dressing, manning, working hours, to dispensing, and counselling habits, record keeping, relationship, follow up and other extras offered (public health campaign in the community, health promotion, etc). Do we have a “standard operating procedure” (SOP) to guide activities or operations in our Pharmacies?  Are we operating a professional premise (a health care centre) OR is it just another provision store next door?

Pharmaceutical care must be embraced as the philosophy of the community pharmacy practice. There is no future in the mere act of pill dispensing and pharmacists must move away from “behind the counter” and start to serve the public by providing care instead of pills. We must embrace the new concept and demonstrate the value of professional pharmacy services by improving patient outcomes and medication use in the community.

Inclusion of disease management in services rendered by community pharmacists could significantly improve the clinical outcomes. Chronic illnesses like hypertension, diabetes and arthritis do not require the patient to visit the clinics regularly. A community pharmacist could take up the responsibility for such patients in consultation with the physician.

Monitoring of therapeutic progress, consulting with prescribers, and collaborating with other healthcare practitioners on behalf of the patients are of utmost importance. HIV/AIDS management is a classical case which the pharmacists must be actively involved in,  outside the hospital system.

It is the duty of the community pharmacist to provide drug information service to the community being served and this include the healthcare workers. The community pharmacist must provide relevant information on drugs and diseases which are important to a given community. Regular publication of bulletins, newsletters, etc, will surely endear a pharmacy to the community. This is also true of research, documentation, and reporting. There is virtually no reliable and published data on drug distribution and utilisation in Nigeria. The community pharmacist can gather useful information from the public, do a proper analysis and publish for professional and or public consumption.

In addition to disease management, there is health prevention and promotion activities that can take place in Pharmacies as part of contribution to public health. A Community Pharmacy can be the centre for immunization, weight reduction, smoking cessation or any other public health related programmes. The community Pharmacists has a high level of contact with often hard to reach drug users. The potential for maximizing such contact must be explored.

Business and technology acumen

Business management skill is important to profitably tap the opportunities of community practice. The community pharmacist must understand the dynamics of a modern-day business and the advantages inherent in group procurement, where substantial discount and favourable terms can be negotiated with manufacturers and importers. This will reduce cost of doing business and improve profitability.

The business must be managed for growth and development through a finance management expertise of keeping a separate record for the business and its owner, as well as involvement of an auditor to check the books and advise on compliance issues.

The world has become a global village and virtually everything, including medicines, can be obtained at the click of a button. The world has gone digital and community Pharmacists must not be left behind as Information Technology (IT) has taken over. In today’s world, access to and frequent use of the Internet must be adopted to solve a lot of problems.

The importance and impact of online pharmacy should not be taken lightly. Online business is the way of the world now and sooner or later, transactions involving medicines will be the norm rather than the exception. It is important for community Pharmacists to seize the moment and lead the way to a sanitised and regulated online pharmacy before it becomes crowded and too late to control.

Home service, therapy monitoring and follow-up of patients can foster a long-term relationship between families and pharmacies. In networking, the community pharmacist needs to expand the horizon of influence to move up the ladder. They must seek networking opportunities to expand their business and professional interests. Now is the time to get out of the unhealthy and worthless rivalry or supremacy battle with the doctors. It is possible to reach out to the GPs in our communities for a professionally enhancing and potentially rewarding relationship. Some pharmacists are already doing it and we can take lessons to upscale.

Attitudinal change, a necessity

For the unlimited potentials of community practice to be fully optimised, there is need for attitudinal change. Pharmacy has always had to contend with attaining a good balance between its mercantile and professional nature. To make an impact in this environment, we must choose the professional path to achieve whatever goal we have set for ourselves.

The attitude towards the profession must change. It must not be seen primarily as a route to affluence anymore but first and foremost as a service to humanity. We must be patient and allow our professional efforts to grow and yield the desired effects, which include professional satisfaction and wealth.

The old ideas, skill and knowledge can no longer work. We must seek retraining opportunities to update knowledge and obtain the necessary skills and competencies. Above all, let us get excellent at the basics. Let us follow the Chinese in the assertion that “the journey of a thousand miles begin with the first step you take.”

Tapping the untapped potentials will not be an easy task. Let us start with the ones that we know very well and move gradually to the ones considered difficult. Attaining professional excellence is a process. Success will be determined by the energy and commitment we put into it.

God bless community pharmacy practice in Nigeria.

By Pharm. (Dr)  Lolu Ojo, BPharm, MBA, PharmD, FPCPharm, FPSN, FNAPharm

 

Great Leaders Leave a Genuine Leadership Legacy (3)

3

LEADERSHIP INTIATIVES FOR EXCELLENCE (LIFE) SERIES

“There is no success without a successor.”

– Peter Drucker

contd from last edition

Abuse or proper use of money, sex and power

One of the most compelling books I’ve ever read is Richard Foster’s Money, Sex & Power: The Challenge of the Disciplined Life. Foster maintains that an undisciplined life is due to the abuse of money, sex and power. The abuse of money is greed. The abuse of sex is lust. And the abuse of power is pride. As I’ve reflected on Foster’s wisdom over the years, it’s amazing how these three abuses seem to be the motive behind every example of unworthy conduct:

Greed can cause people to inflate corporate profits; participate in “insider trading” on the stock market; defraud others through identity theft and get-rich schemes; become addicted to gambling; rob banks; embezzle or extort money; misrepresent products; and numerous other fraudulent activities.

Lust can lead to divorce, dysfunctional families, incest, sexual abuse, prostitution, drug addiction, AIDS and other sexually transmitted diseases, abortion, pornography, rape, and a variety of other lewd acts too graphic to mention. Pride can lead to insecurity; an unwillingness to accept blame; a refusal to share credit; a disdain for taking responsibility; a desire to control or micro-manage others; a penchant for boastfulness, excessive ego and drawing attention to self; and on and on.

In addition, greed, lust and pride can lead to financial disaster, lawsuits, imprisonment, disease, sickness, premature death, shame, stress, depression, disappointment, failure, and a loss of respect, dignity and self-esteem – just to name a few of the many consequences of a wayward conduct.

Thankfully, there’s a good side to money, sex and power. Instead of being greedy, we can choose to be generous with our money. Instead of being lustful, we can choose to be respectful of the real reasons for sex—procreation and intimacy between a married man and woman. Instead of being prideful, we can choose to use power in a constructive manner. In fact, here’s what Foster recommends:

When it comes to money, think simplicity.

When it comes to sex, think fidelity.

When it comes to power, think service.

Simplicity means living within our means, so we’ll have more money to share with other people and for worthy causes. Fidelity means being faithful to our spouses if we’re married, and respectful of the opposite sex if unmarried. Service means we’re not leading for selfish reasons, but because we care about people and want to use our power to help others reach their potential.

Mentoring matters

One of the best ways to be accountable for our conduct is through the one-on-one leadership concept of mentoring. Rev. Sister Margaret, Rev. Fr Mc Comboy and Prince Julius Adelusi-Adeluyi are just three of my many mentors, apart from my parents who modelled my character, commitment and competence. They are leaving a legacy that has encouraged me to also mentor others. I constantly remind my mentees to continuously invest to improve their competencies, take good care of their character and be passionately committed to whatever they choose to do.

One of the reasons why I am so passionate about mentoring is because I know what a difference it has made in my life. I have been privileged to have been mentored by many along the way but I have been significantly impacted by the guidance provided by the likes of F. O Odujobi, Paul Enebeli, Stella Otuyemi, Robert Tade, J. K. Adesina, George Thorpe and Sam Ohuabunwa. They all believed that I had some raw skills that could be developed and shaped. They all worked hard for over three decades to shape me and hone some aptitudes in marketing, strategy and leadership. Like all great mentors, they saw me for what I could become – a young man with great potential, if well managed; and not for who I was – an immature aggressive young graduate. I don’t say this boastfully, but to give credit to my mentors.

I am forever grateful to my parents and these mentors. They modelled sound character; helped me make some wise choices; and inspired me to act honourably. The consequences have produced bountiful blessings for more than three decades.

Benchmarks of a master mentor

I know mentors can influence conduct because I’ve observed it in my several mentors. I distinguish a mentor from a master mentor because anyone with more experience than someone else can be a mentor, but only a master mentor will make the time to share his or her wisdom and experience with a protégé. My curriculum is based on these four lifetime benchmarks of a master mentor:

Master mentors pursue what is true.

Master mentors turn creeds into deeds.

Master mentors use congruence to influence.

Master mentors collect a deep respect.

The first two benchmarks reveal the mind-set of a master mentor. Pursue what is true is rooted in sound character and manifested in wise choices. Turn creeds into deeds is about meaningful conduct.

The last two benchmarks deal with the multiplication of master mentors. Use congruence to influence and collect a deep respect are the consequences of spending time with protégés. When a mentor’s creeds and deeds are congruent, there’s a greater opportunity to influence a protégé in a positive manner. Then, out of respect for these master mentors, a protégé teaches what he or she has learnt to other protégés. Multiplication takes over and the consequences are amazing.

The legacy of the master mentor is passed on like a baton in a relay race. In the process, protégés determine or fine-tune their destinies and eventually leave legitimate leadership legacies of their own.

The fourth standard for leaving a legitimate leadership legacy is CONSEQUENCES – having the harvest of what’s sown. The Bible provides a superb definition of consequences in Galatians 6:7: “Don’t be misled. Remember that you can’t ignore God and get away with it. You will always reap what you sow.”

But isn’t it true that some people don’t seem to reap what they sow? For instance, a person may behave badly by robbing a bank and reap something good by getting away with the money. On the other hand, a person may behave well by stopping to help a stranded motorist and reap something bad such as getting attacked. It’s a fact that life isn’t always fair; so why does the Bible say we always reap what we sow?

Perhaps the greatest manifestation of this principle is the conscience. Whether we’re brought to justice for our reprehensible conduct or we manage to elude accountability for a lifetime, none of us can escape that inner voice that knows the truth and the reasons why bad behaviour is never acceptable. Besides, people who continue to practice illegal or unethical conduct in spite of some good consequences are likely to get what they really deserve in due time. Conversely, people who continue to sow seeds of kindness in spite of some bad consequences are likely to get what they truly deserve in due time as well.

To change or not to change?

An ancient proverb defines insanity as “doing the same thing over and over again while expecting to get a different result.” If we want to increase our chances of reaping good consequences, we must change our conduct. Since much of exemplary conduct is tied to our habits, we must learn discipline, which is the ability to change our bad habits into good ones.

A self-disciplined person is often faced with the headache of changing, or the heartache of not changing. For example, when we try to change the bad habit of procrastination into the good habit of “doing it now,” it can be a big headache. On the other hand, isn’t it also likely that we could suffer the greater pain of heartache by missing out on some golden opportunities because we’re unreliable?

When it comes to changing our consequences, consider these thoughts:

No change is impossible. Even if we retreated to a cave to escape the stress of life, we’d still experience change–aging, adjusting to loneliness, hunting for food, sleeping outdoors, etc.

Some change is impractical. The Ten Commandments have never been edited because these truths are timeless. The U. S. Constitution has only been amended 27 times in more than two centuries because it was written with such wisdom.

Most change is uncomfortable. This is especially true when we experience painful turning points such as divorce, financial setbacks, job losses, health challenges, and the death of loved ones, just to name a few of life’s major transitions.

Every change has consequences. For those who have changed from a sedentary lifestyle to a regular exercise routine, there can be radical consequences ranging from the initial soreness and physical exhaustion, to more long-term results such as weight loss, higher energy, less stress, lower cholesterol, etc.

We don’t always get the consequences we want because many things in life are out of our control. However, we are in charge of our habits and conduct. In the long run, we’re more likely to experience favourable consequences when we develop good habits and conduct ourselves accordingly. If you’re unhappy with the consequences you’ve been getting out of life, have the courage to quit doing what you’ve always been doing. Isn’t a headache now a lot better than heartache later on?

 

It’s About Thyme

0

Thyme is an herb from the mint family. Thymus vulgaris L. (Fam. Lamiaceae) appears to be the most popular species of thyme found in Nigeria. It is called kasahorow in Hausa.

Constituents

Thyme is rich in fibre, vitamins A and C, calcium, manganese, magnesium, copper, iron and potassium. It also contains oleanolic acid, ursolic acid, lutein, and beta-sitosterol, thymol and carvacrol.

Preparations

Thyme leaves may be used fresh, dried, or ground as an infusion or a tincture. It can be used in a steam tent for help with cold and congestion or as a mouthwash. Thyme leaves may be presented as capsules or in oils. Thyme is a wonderful ingredient that is used in cuisines around the world to flavour different kinds of meat, fish and some food.

Pharmacological actions and medicinal uses

Though it was used in embalming practices and as incense by the ancient Egyptians and ancient Greeks, respectively, thyme is fast gaining a reputation for its medicinal qualities. As far back as 370 BC, Hippocrates, also called the Father of Western Medicine, recommended thyme for respiratory ailments. Thyme was used traditionally to treat respiratory ailments like bronchitis, sore throat and cough.

Various studies found out that thyme reduced blood pressure in rats that had high blood pressure. It also reduces cholesterol and has natural diuretic properties. Reports suggest that essential oil of thyme like thymol hold many fungicidal, antibacterial and antiviral properties; thus thyme can be used as a disinfectant and is a common ingredient in mouthwash and natural deodorants. Studies also show that thyme extract can act as pesticide, repelling mosquitoes, rats, mice, and other animal pests.

In a 2013 study, carvacrol was shown to affect neuron activity in ways that boosted the subjects’ feelings of well-being, relieving headache and stress. Thyme has been found, in a study, to improve the symptoms of dyspraxia, especially in children.

Studies revealed that thyme may help prevent cancer, especially that of the colon and breast by potentially increasing cancer cell death and inhibiting the proliferation and migration of cancer cell lines.

Studies have shown that thyme oil can suppress COX-2, which is an inflammatory enzyme that leads to several inflammatory ailments; thus its usefulness in the management of painful symptoms of arthritis and gout as well as dysmenorrhea.

Thyme also supports the formation of white blood cells, thereby boosting the immune system

Thyme is known to have carminative and antispasmodic properties, and helps relieve intestinal cramps thereby boosting digestive health. Studies show that thyme might have properties to improve vision

Thyme oil is reported to heal sores, wounds, scars, and cuts. It even relieves burns and acts as a natural remedy for skin conditions such as eczema. And since thyme is high in antioxidants, it can slow down the aging process and give healthy and glowing skin. Studies show that when combined with other herbs, thyme may promote hair growth.

In manufacturing, thyme oil is used in perfumes, soaps, cosmetics and toothpastes.

 

Adverse effects

Thyme may slow down blood clotting. This might increase the risk of bleeding if taken in large amounts. Thyme may also cause skin irritation, allergic reactions, dermatitis and abdominal pain

Economic uses and potentials

Belgium is the third-largest importer of dried thyme in Europe. In 2019, Belgian imports of dried thyme reached 0.9 thousand tonnes, worth €2.2 million. A popular brand of dried thyme leaves cost between ₦900 – ₦1300 per 100g. A bunch of fresh thyme leaves costs ₦500. There are prospects in the cultivation, sales and use of thyme in medicine, cosmetics and beverage.

Gbagada COVID-19 Isolation Centre to Become Fee-Paying Facility -Sanwo-Olu

1

Governor Babajide Sanwo-Olu says the Lagos Government is making efforts to transform the state-owned isolation centre in Gbagada into a fee-paying facility that people could elect to be treated at.

The News Agency of Nigeria reports that Sanwo-Olu made this known on Sunday in a statement in which he updated residents on the management of COVID-19 in the state.

He said that the decision was due to the growing clamour by patients and families that are willing to pay for COVID-19 treatment, but would like to do so at a cost that is lower than what currently obtains in private facilities.

Babajide-Sanwo-olu

“This means that the COVID-19 treatment facility in Yaba will continue to offer free and high-quality treatment to all persons.

“Gbagada centre will offer treatment at a moderate and affordable cost to those who wish to take advantage of extra offerings like private treatment rooms and more personalised levels of care,” Sanwo-Olu said.

He said that the government established a telemedicine service, EKO Telemed, for patients who were either asymptomatic or had mild symptoms that did not require admission and could, therefore, be managed in the comfort of their homes.

He encouraged as many people as possible, whose cases fell in the asymptomatic or mild category, to take advantage of the service.

Sanwo-Olu said that, so far, about 5,000 patients had been reached through EKO Telemed and more than a thousand care packs delivered to patients in the home-based care programme.

It may be recalled that on May 1, 2020, the Lagos State Government unveiled a 118-bed COVID-19 isolation and treatment Centre at the Gbagada General Hospital, Lagos.

This was disclosed by the Lagos State Ministry of Health via its verified Twitter handle @LSMOH.

The ministry had tweeted: “COVID19Lagos Update. Breaking! @jidesanwoolu Commissions 118-bed Isolation and Treatment Centre at Gbagada General Hospital.”

(NAN)

Innovate or Fizzle Out, Oyawole, Adeniran, Others Task Community Pharmacists

3

– As Lagos ACPN holds 2020 Continuing Education Conference

Notable personalities in pharmacy practice, including Pharm. Anthony Bola Oyawole, a former presidential aspirant of the Pharmaceutical Society of Nigeria (PSN); Pharm. (Mrs) Bolanle Adeniran, immediate past chairman, PSN, Lagos State; and Pharm. Iyiola Gbolagade, chairman, PSN, Lagos State, have called on community pharmacists to reinvent themselves and upgrade their practice, noting that it is either they innovate or become history.

The dignitaries gave the charge at the Continuing Education Conference of the Association of Community Pharmacists of Nigeria (ACPN), Lagos State Chapter, held recently at the chapter’s secretariat in Ogudu, Lagos.

According to Pharm. Oyawole who spoke with our correspondent, the conference was timely and apposite, as knowledge gained would help participating pharmacists to keep their businesses afloat during the current pandemic.

He said: “For any professional, it is about continuous development because the world we are living in today is a changing world and as pharmacists, we must move with the change. The world was greeted with the COVID-19 pandemic, and since then, the whole world has not been the same. So, the only thing we can do to be ahead of our practice is to seek knowledge.”

Oyawole also seized the opportunity to call on government to give community pharmacists the recognition they deserve, saying pharmacists are being made use of judiciously in advanced countries as they are the closest healthcare providers to the people.

Also speaking in an interview with Pharmanews, Pharm. (Mrs) Adeniran disclosed that the continuing education conference was a good avenue to update the knowledge of community pharmacists so that they can remain leaders in the pharmaceutical business.

She added that lack of updated knowledge makes even a professional become archaic. “Drugs are evolving; diseases are evolving. So, if we stay on what we learnt or acquired in school alone, we would not be able to move with the tide,” she said.

Speaking in the same vein, Pharm. Gbolagade commended the leadership of the ACPN for sustaining the programme which has spanned over ten years, as well as continually enriching its content.

While lamenting the unconducive environment of community pharmacy practice in the state as a result of unfriendly policies and regulations as well as quackery,  Gbolagade advised pharmacists to take advantage of the many opportunities offered by the programme to enhance their businesses.

Speaking earlier, Chairman of ACPN Lagos State, Pharm. Olabanji Obideyi, who was represented by Pharm. Lawrence Ekhator, the vice chairman, disclosed that the Continuing Education Conference with the theme, “Innovate or Fizzle Out”, was designed to promote professional skills, business strategy skills, and practice skills of community pharmacists, saying it would help community pharmacists to better understand current economic realities and the options available for small and medium enterprises.

According to him, the programme was initiated to constantly educate members on current changes in the profession and keep them up to date.

“Talking about the theme, ‘Innovate or Fizzle Out’, we are now in a new normal and things are no longer the way they used to be. So, for us to remain relevant, there is a need for innovation and rededication”‘, he said.

NMA’s Opposition to Pharmacist Consultant Cadre Egoistic, Says PSN

2

-Urges FG to ignore NMA’s call for withdrawal of circular

There seems to be no end in sight to the crisis rocking the implementation of the consultant cadre for pharmacists in the country, as the leadership of the Pharmaceutical Society of Nigeria (PSN) has berated the petition of the Nigerian Medical Association (NMA) to the Federal Government for the suspension of the cadre, describing it as purely self-centered rather than altruistic.

NMA President, Prof. Innocent Ujah, had petitioned the Secretary to the Government of the Federation (SGF), Mr Boss Mustapha, on behalf of the association, requesting the suspension of the consultant pharmacist cadre, arguing that it is “capable of causing disruptions in healthcare delivery system in the hospital, as it blurs the lines of competence and responsibility among different cadres and profession in the healthcare industry”.

In the 5 November 2020 communique, titled “Consultant Pharmacist Cadre: Danger to the Fragile Health System” and signed by the NMA president, the association stated several reasons why the consultan cadre should not be implemented for pharmacists.

#ENDSARS:PSN President Laments Killing of Nigerian Youths, Says it’s Shameful
Pharm.(Mazi) Sam Ohuabunwa

However, in a swift reaction to the petition, the PSN has urged the Federal Government to ignore the call by the NMA, saying it negates global best practice.

Also, in a related development, a Nigerian medical doctor practising in the United States, Dr Anurika Ndidi, had earlier condemned the NMA and its president for opposing the approved consultant cadre for pharmacists in the country.

In a statement addressed to the NMA president, Ndidi described the NMA’s stance as shameful to the medical profession, saying it smacks of inferiority complex.

She said: “I became ashamed at how low the decision makers in Nigeria stooped to drag against what should be applauded and encouraged. I saw the unnecessary letter as a show of shame to doctors, which makes it look as if we now feel less of ourselves. I was never trained to feel less of myself.

“Thinking that someone becoming a consultant in Nursing or Pharmacy or even Laboratory will take job away from consultants in Medicine is a wrong judgement, Mr President,” she flayed.

The PSN, in a statement addressed to the Minister of Health, Dr Osagie Ehanire, and obtained by Pharmanews, stated that contrary to the NMA’s position, implementing the consultant pharmacist cadre will make the healthcare system better than what it is presently.

“In the light of the foregoing, in line with global best practice and given the immense benefits of the consultant pharmacist cadre to the healthcare system of our dear country, we urge Your Excellency, to ignore the petition of the leadership of NMA and appropriately disregard their call for the withdrawal of the circular of the Consultant Pharmacist cadre in Nigeria. Nigeria’s health system shall be better off with this cadre.

“NMA’s position is purely egoistic rather than altruistic. Permit us also to add that this growing penchant of the NMA to often challenge decisions of government and impose its self-centered wishes through blackmail (strike action) must be strongly reprimanded. Otherwise, it might create so much dissonance and entropy where every other professional group would dictate to government not only what it wants but also what it approves for other professional groups”, PSN maintained.

Countering the NMA’s petition that the circular for the approval of the pharmacist consultant cadre was hastily released without following due process, the PSN insisted that the document followed due process and fulfilled all the requirements as stipulated by the National Council on Establishment (NCE).

“Sir, it is appropriate to inform you that the NCE had in August 2011 given approval for the creation of the Pharmacist Consultant Cadre. This approval followed the receipt and adoption of the recommendations contained in a report of its technical committee on the review of the Scheme of Service and creation of consultant pharmacist cadre in the public service. However, owing to reasons beyond our comprehension, the follow-up circular was not released.

“In 2015, in an apparent attempt at releasing the circular, the Office of Head of Civil Service of the Federation (OHCSF) dispatched a letter dated 28 July 2015 (reference no: HCSF/EPO/EIR/NCE/100/S.6/T/56) to the Permanent Secretary, Federal Ministry of Health (FMoH) requesting for his views/comments and inputs before the release of the circular as approved by the NCE in 2011. The FMoH responded via a letter dated 5th October 2015 (reference no: C4007/T4/315) in which the ministry reaffirmed its full support for the creation of the consultant cadre for pharmacists.

“How on earth can a process of review of the scheme of service which started with the submission of a memorandum to NCE in 2007 culminating in the release of the circular in 2020, thirteen (13) years down the line be said to be hastily done”, the PSN queried.

“The leadership of NMA needs to appreciate the fact that modern healthcare delivery is not indigenous to Nigeria but was imported from the developed world where the roles and responsibilities of each healthcare professional are well defined within the framework of its acquired competencies” it stated.

Spirituality and Wellness

0

It has been scientifically established that human beliefs, which form part of spirituality, may enhance general wellbeing, especially during periods when humans are faced with health challenges. Psychological fortitude, mental stamina and a strong sense of optimism, driven by one’s religious inclinations, may increase healing speed in persons with trauma and other forms of physical or psychological injury.

Many religions of the world propagate the worldview that embracing and living according to the will of God provide an everlasting insurance cover from the infirmities of this world. For Christians, in particular, there are many biblical references which show that God is self-sufficient in ensuring that those who truly believe in Him enjoy good health, even when they are confronted with the stark reality of sickness. He is referred to as the Balm of Gilead and has been celebrated in many gospel songs as the Master Healer. It is believed that meditation and constant devotion to God through prayer, praise and worship can alleviate certain emotional conditions and bring healing to the mind and body.

During the Romantic Literature era, most popular poets and writers were deeply connected to the rationalisation of nature as a great source of creative inspiration that let loose the muses in them. To a large extent, many of them found a profound sense of spirituality in nature, from which they later developed the concept of pantheism in Romantic Literature. They held strongly to the belief that nature was the centre of all life and an intertwining part of divinity.

Mr Patrick Iwelunmor

Poets like Wordsworth, Coleridge, Keats, Tennyson and Blake found unparalleled succour in nature whenever they were faced with situations that compromised their emotional freedom. To access emotional healing and stability, they embraced nature. It was either by watching the ocean waves roll or listening to the sweet songs of the birds. Essentially, the nature-divinity nexus brought about some kind of therapeutic experience. For some of them, meditation was all they needed to escape from the emotional trauma that haunted them. The concept of escapism which was very popular with romantic poets also shaped the attitudinal orientation of many writers of that age.

According to WebMD – a popular health-based website – “Any condition that is caused or worsened by stress can be alleviated through meditation, says cardiologist Herbert Benson, MD, well known for three decades of research into the health effects of meditation. He is the founder of the Mind/Body Institute at Harvard Medical School’s Beth Israel Deaconess Medical Center. The relaxation response [from meditation] helps decrease metabolism, lowers blood pressure, and improves heart rate, breathing, and brain waves. Tension and tightness seep from muscles as the body receives a quiet message to relax.

There is scientific evidence showing how meditation works. In people who are meditating, brain scans called MRI have shown an increase in activity in areas that control metabolism and heart rate. Other studies on Buddhist monks have shown that meditation produces long-lasting changes in the brain activity in areas involved in attention, working memory, learning, and conscious perception.”

In Nigeria and many African countries where people suffer from poverty-induced depression, the sight or possession of money can trigger incredible recovery and this makes some people ignorantly worship money as the centre of their existence.  Of course, it can be argued that the possession of money improves mental health because the lack of it could spell doom; yet, money can never give the reassuring peace that comes from embracing God as the backbone of one’s existence.

There is, indeed, a powerful nexus between spirituality and health, especially now that the world is overburdened with many cares, particularly the noisome pestilence of COVID-19.  Spirituality offers the best form of solace, even as we explore therapeutic options and take necessary precautions.

COVID-19 May Damage Sperm, Reduce Male Fertility, Study Suggests

0

COVID-19 may damage sperm quality and reduce fertility in men, according to a new study based on experimental evidence.

Experts commenting on the research, however, said the capacity of the virus to compromise fertility in men remains unproven.

The viral disease — which has swept the globe, claiming nearly 2.2 million lives — can cause increased sperm cell death, inflammation and so-called oxidative stress, researchers reported Friday in the journal Reproduction.

A new study has shown that COVID-19 may lead to infertility in men by blocking testicular cells that produce sperm, a new study has claimed.

“These findings provide the first direct experimental evidence that the male reproductive system could be targeted and damaged by COVID-19,” the authors concluded.

Experts commenting on the research, however, said the capacity of the virus to compromise fertility in men remains unproven.

COVID-19 causes respiratory illness, especially in older people and those with underlying medical problems.

The world has seen more than 100 million confirmed cases since the disease emerged in central China at the end of 2019.

Transmitted through respiratory droplets, the disease attacks the lungs, kidneys, intestines and heart.

It can also infect male reproductive organs, impairing sperm cell development and disrupting reproductive hormones, earlier studies have shown. The same receptors the virus uses to access lung tissue are also found in the testicles.

But the effects of the virus on the ability of men to reproduce remained unclear.

Behzad Hajizadeh Maleki and Bakhtyar Tartibian from Justus-Liebig-University in Germany searched for biological markers that might indicate a negative impact on fertility.

Analysis done at 10-day intervals for 60 days in 84 men with COVID-19 was compared to data for 105 healthy men.

In the COVID-19 patients, sperm cells showed a significant increase in markers of inflammation and oxidative stress, a chemical imbalance that can damage DNA and proteins in the body.

‘Strong note of caution’
“These effects on sperm cells are associated with lower sperm quality and reduced fertility potential,” said Maleki in a statement.

“Although these effects tended to improve over time, they remained significantly and abnormally higher in the COVID-19 patients.”

The more severe the disease, the bigger the changes, he added.

The male reproductive system “should be considered a vulnerable route of COVID-19 infection and declared a high-risk organ by the World Health Organisation,” Maleki said.

Experts not involved in the study welcomed the research, but cautioned that more was needed before drawing hard and fast conclusions.

“Men should not be unduly alarmed,” noted Alison Campbell, director of embryology of the CARE Fertility Group in Britain.

“There is currently no definitive evidence of long-lasting damage caused by COVID-19, to sperm or male reproductive potential,” she told the London-based Science Media Centre.

The results could have been skewed, she added, by the fact that men recovering from Covid were treated with corticosteroids and antiviral therapies, while the control group was not.

Allan Pacey, a specialist in male reproductive medicine at the University of Sheffield, raised a “strong note of caution” on how the data was interpreted.

Some of the indicators of decreased sperm quality could be due to factors besides COVID-19, he said, noting that more men in the COVID-19 group were overweight.

The simple fact that only one group was very sick — no matter the cause — also needed to be taken into account, he added.

“We already know that a febrile illness can impact on sperm production, regardless of what caused it.”

(AFP)

Onyema Ogbuagu – Superhero of COVID-19  Vaccine

2

A deadly plague sweeps through the world with rage

Darkness descends, re-enacting the medieval Black plague

Mighty and small, old and young fall in their thousands

Yet the pestilence craves more with reckless abandon

Sages and mages race to fathom the evil albatross

But a hero from the third world kindles our hope

A new dawn has come, the plague is at bay

Onyema Ogbuagu

And all who live will remember his name…

After several months of painstaking research and clinical trials, the long awaited vaccine for the deadly coronavirus has finally been produced. The COVID-19 pandemic, which has been tagged the worst public health crisis of our time, has infected more than 80 million people worldwide and claimed more than 2 million lives as at 19 January 2021.

However, due to the diligence and brilliance of the research team of the pharmaceutical giant, Pfizer, and their partner BioNTech, led by Dr Onyema Ogbuagu, the coronavirus vaccine, projected to take two years to develop, has been produced in record time of less than eight months. Before now, the average time to develop and make a vaccine publicly available was about 16 years. In fact, the only other vaccine that has ever come close to matching the current COVID-19 vaccine in pace of development is the mumps vaccine, which still took about four years to get all necessary permissions and licensing.

The Pfizer-BioNTech vaccine which was first approved for use in the UK on 2 December 2020 is the first internationally recognised COVID-19 vaccine approved by the World Health Organisation (WHO), after having completed all mandatory stages in vaccine development. The Russian and the Chinese vaccines which were earlier released in August, 2020 did not complete the mandatory Phase III trials before they were approved.

Interestingly, the Pfizer-BioNTech vaccine which Ogbuagu helped develop has been shown to be the most efficacious vaccine, recording up to 95 per cent effectiveness even against new emerging strains of the coronavirus. The vaccine was tested on 43,500 people in six countries without any safety concerns being raised during its clinical trials. Pfizer has said it will be able to supply around 1.3 billion doses by the end of 2021. This, according to medical experts, will go a long way in curbing the spread of the virus by providing immunity to many and reversing the recent trend of the daily increase of COVID-19 fatalities around the world.

Specialty and interests

Dr Onyema Ogbuagu is a Nigerian born American infectious disease specialist and associate professor of medicine at Yale School of Medicine, Yale University, USA. The medical doctor who directs the university’s HIV/AIDS clinical trials research programme and the institution’s clinical studies around COVID-19 has spent his career investigating some of the world’s most pervasive infectious diseases including Ebola, SARS and MERS. He has also provided care for COVID-19 and HIV/AIDS patients.

Ogbuagu and his team were able to produce the Pfizer vaccine in record time because they did not have to develop it from scratch. The team had previously worked on the MERS viruses which belong to the coronavirus family during the outbreak in 2012; and the SARS virus outbreak in 2003. Moreover, the novel mRNA vaccine development technique which Ogbuagu and his team employed is faster, compared to the well-known protein vaccine development. The mRNA technique does not require a researcher to produce protein or weakened pathogens for the vaccine development.

The genetic material mRNA is easy to make in a laboratory and manufacturing an mRNA vaccine rather than a protein one can save months in time. Ogbuagu’s ground-breaking research in the field of modified genetic code and mRNA technology has made him the cynosure of all eyes, and his role as the principal investigator of the Pfizer team which developed the coronavirus vaccine has brought him global recognition.

 

Background and education

Onyema Ogbuagu was born to the family of Chibuzor and Stella Ogbuagu in New Haven, Connecticut, USA, while they were pursuing their doctorate degrees in Yale. Onyema’s father was a former vice-chancellor of Abia State University, Nigeria, and his mother was a professor of sociology who was the best graduating student of the class of 1974 at the University of Nigeria, Nsukka (UNN).

Born as a twin, Ogbuagu’s brother is an accomplished engineer. The family later moved back to Nigeria where the twins had their secondary and university education.

Ogbuagu graduated from the School of Medicine, University of Calabar, Nigeria in 2003. After graduation, he had his medical internship/housemanship at the Ebonyi State University Teaching Hospital, Abakaliki, Nigeria. He then went back to the United States where he also interned at Mount Sinai School of Medicine (Elmhurst), New York, USA. He became a resident doctor at the institution and then rose to become chief resident at the same school.

Ogbuagu became a fellow of infectious diseases, Yale University School of Medicine, and then rose to the height of an associate professor of medicine at the same institution. He has worked there for over five years, focusing on finding a cure for HIV/AIDS. He has been the principal investigator on numerous pharmacokinetic, phase 2 and 3 safety and efficacy trials of novel antiviral compounds.

The associate professor has led several researches in the US and Africa. He worked in the faculty of the human resources for a health programme in Rwanda, where he mentored medical residents and junior faculty in clinical research projects locally relevant in addressing important infectious diseases-related problems (particularly HIV/AIDS and antimicrobial resistance). He has also worked at the Liberia College of Physicians and Surgeons (LCPS).

 

Awards and recognitions

In 2015, Ogbuagu was a Fellow of the American College of Physicians. In 2017, he was a nominee for Charles W. Bohmfalk Award in Clinical Science, Yale University School of Medicine. In the same year, he won the Steve Huot Faculty Award for Dedication and Excellence, Yale University School of Medicine Internal Medicine Primary Care programme.

In 2019, Ogbuagu was awarded the Gerald H. Friedland award for outstanding international research. In 2020, he emerged as a nominee for Charles W. Bohmfalk Award in Clinical Science, Yale University School of Medicine. Indeed, from all indications, many more awards are bound to follow in the coming months and years!

Our Personality For The Month is Pharm. Babatunde Samuel Aremu

2

Pharm. Babatunde Samuel Aremu, (popularly called Babsam) is a man with an uncommon passion  for the pharmacy profession. Born on 3 February 1971 in Lagos, he had his primary education at UPE School 1, Festac Town, between 1978 and 1984, before proceeding to Awori Ajeromi Grammar School, Agboju, where he obtained his WASC in 1989 and emerged as one of best three graduating students for that set.

Having been denied admission to study his dream course, Pharmacy on his first and second attempts, he temporarily dropped his “Pharmacy or nothing” mantra and quickly settled for admission into Yaba College of Technology to study Food Science and Technology. He graduated with a National Diploma in 1994, again as the second best graduating student.

However, he attempted another JAMB, and this time, he was not only given admission to study Pharmacy but was one of the eight candidates admitted on merit into the prestigious University of Lagos, Akoka. He obtained his B.Pharm degree in 1999.

As a pharmacy undergraduate, Babsam distinguished himself both academically and in sport. Upon graduation, he acquired a brief hospital pharmacy experience, first as an internee at UITH, Ilorin, and later as a Youth Corps member EBSUTH, Abakaliki.

Putting the hospital settings behind, Babsam settled for community practice in 2002 when he established the now popular pharmacy in the Ilorin metropolis called Babsam Pharmacy and Stores Limited. The pharmacy now has a branch office.

Babsam has served the pharmacy profession in various capacities and at different levels. He was secretary and chairman, Association of Superintendent Pharmacists (ASP), Kwara State (2002-2006). ASP was a locally built umbrella body of superintendent pharmacists set up to specifically protect the interests of pharmacy professionals who registered and worked for non-pharmacists.

He also served as acting secretary, ACPN Kwara State (2007-2008); general secretary, ACPN Kwara (2008-2011); general secretary PSN Kwara State (2011-2014), chairman, Kwara State Copharm (2014 to date), secretary, Kwara State Copharm (2011-2014), chairman, ACPN Kwara State (2014-2017), NEC member PSN (2011-2014), chairman, LOC for the 33rd ACPN Annual National Conference (2014), member, CPC, ACPN National Conference (2014, 2020), chairman, Accommodation Subcommittee for PSN National conference (Harmony 2013), current national financial secretary, ACPN

Babsam is happily married to Mrs Kehinde Aremu and the union is blessed with children.

Kano Immunises Over 44,000 Children Against Polio

0

Over 44,000 children below the age of five years have been immunised in Gabasawa Local Government Area of Kano for the January round of the Immunisation Plus Days. 

Alhaji Sani Dawaki, the Primary Health Care Coordinator in the area revealed this on Wednesday during the evening review meeting at Gabasawa, Kano.

The coordinator attributed the success of the exercise to the efforts of the District Head of the area, the Fulani leaders as well as Ward Heads who mobilised their subjects.

In his comments, the District Head of the area, Alhaji Sani Dawaki, called on health workers to put more efforts to ensure a polio-free Kano.

Meanwhile, Mr Ahmad Ayuba, the Immunisation Manager of the local government called on parents to always immunise their wards at every round of the exercise. 

He urged them to take their newborns for routine immunisation to keep them healthy.

The News Agency of Nigeria reports that the exercise, which began on Saturday, across the 44 local government areas of the state ended on Wednesday. 

(NAN)

Which of the following agents belongs to psychostimulants?

4

Which of the following agents belongs to psychostimulants?

a) Meridil

b) Camphor

c) Piracetam

d) Pantocrin

Experts Associate More Sex to Lower Risk of Early Menopause

0

Experts from University College London (UCL) have recently shed more light on women’s sex life, saying women who engage themselves more in sexual activities are less likely to enter into an early menopause.

The research showed the possibilities that lifestyle factor has more important roles to play than previously thoughts in determining when the menopause occurs.

The study shows how many data that was collected from 3,000 women who were followed for 10 years. It shows that those who reported engaging in sexual activity weekly were 28 per cent less likely to have experienced menopause at any given age than women who engaged in sexual activity less than monthly.

Experts Associate More Sex to Lower Risk of Early Menopause

The study’s first author, Megan Arnot said the findings explained that if a woman is not having sexual intercourse, and there is no chance of pregnancy, the body might choose not to invest in ovulation.

“There may be a biological energetic trade-off between investing energy into ovulation and investing elsewhere, such as keeping active by looking after grandchildren,” she said.

The findings are based on data collected from 2,936 women recruited into a US menopause study called the SWAN cohort in the 1990s. The women were aged 45 years on average at the start of the study and were mostly married or in a relationship.

The women were asked to respond to several questions, including whether they had engaged in sex with their partner in the past six months, the frequency of intercourse, including whether they had engaged in sexual intercourse, oral sex, sexual touching or caressing in the past six months, and whether they had engaged in self-stimulation in the past six months. The most frequent pattern of sexual activity was weekly (64 per cent).

None of the women had yet entered menopause, but 46 per cent were starting to experience early menopause symptoms, such as changes in period cycle and hot flushes. By the 10-year follow-up, 45 per cent of the women had experienced a natural menopause at an average age of 52.

The study, published in the journal Royal Society Open Science, found that women of any age who had intercourse weekly were 28 per cent less likely to experience the menopause compared with those who had intercourse less than monthly. Those who had intercourse monthly were 19 per cent less likely to experience menopause at any given age compared with those who had intercourse less than a month.

The researchers have yet to establish what the biological mechanism might be that would result in sexual activity actively influencing when a woman’s reproductive cycle comes to an end.

The menopause is thought to occur when the number of maturing egg follicles in the ovaries drops beneath a critical threshold.

One possibility is that sexual activity stimulates the release of oestrogen, which plays a role in the complex cascade of chemical signals that result in an egg being released each month before the menopause. But the study did not test this directly. A challenge, Arnot said, is that “the whole hormonal mechanisms surrounding the menopause is really poorly understood”, meaning the work does not slot neatly into a well-established framework.

Another possibility is that the two factors – how often a woman has intercourse and age at menopause – are both determined by some other hormonal or biological factor that was not measured in the study. In this case the link would not be causal.

The study looked at whether living with a male partner played a part but found no link, suggesting that exposure to male pheromones did not explain the findings.

Prof. Ruth Mace, an evolutionary anthropologist at UCL and the paper’s senior author, said: “The menopause is, of course, an inevitability for women, and there is no behavioral intervention that will prevent reproductive termination. Nevertheless, these results are an initial indication that menopause timing may be adaptive in response to the likelihood of becoming pregnant.”

Illegal Reopening of Closed Pharma Facilities Might Lead to Blacklisting, NAFDAC Warns

1

– As PMG-MAN supports agency’s action

Following the recent closure of six pharmaceutical companies by the National Agency for Food and Drug Administration and Control (NAFDAC) over alleged failure to comply with Good Manufacturing Practice (GMP) regulations, the agency has issued a strict warning to the affected companies not to attempt reopening their facilities without approval, stressing that such may aggravate their penalties.

The agency further disclosed that its officials are keeping constant surveillance on the six companies based on the written agreement signed with them, warning that any attempt to violate the closure order might lead to worse sanctions.

“The companies are placed under strict written commitment not to violate closure order as they are fully aware that the consequences of re-opening without approval far outweigh the temporary closure, as they run the risk of permanent closure, de-registration, blacklisting and prosecution,” it stated.

Speaking in an exclusive interview, the Director General, NAFDAC, Prof. Moji Adeyeye, explained how the defaulting companies had been served notice of upgrading of their facilities for almost two years without their acknowledgement of the notice nor submission of an action plan for the correction of defects.

Adeyeye further disclosed that the nonchalant disposition of the concerned companies compounded their cases, as they allegedly never made any attempt to address the issues raised nor communicated with the agency.

She said the initial audit conducted by the agency early 2019 had identified 15 companies producing drugs in substandard facilities, adding that after an enlightenment workshop for their management teams, nine of the companies braced up and commenced action plans to improve, while the conditions of the remaining six deteriorated beyond measures

“The defaulters were notified in the early 2019 to submit a plan of action within 30 days targeted at addressing non-conformance observed during the nationwide audit of all manufacturers in 2018/2019. There was no response from the companies.  Fifteen companies fell into the category.

“In order to understand how to address the non-conformance, NAFDAC conducted a training in mid-2019.  The plan of action was to demonstrate their commitment to Good Manufacturing Practice (GMP) corrective and preventive actions (CAPA) on both capital intensive and non-capital-intensive deficiencies.

“The main issue was that the defaulting companies did not acknowledge nor respond to the official notification issued to them, despite the fact that all manufacturers were trained on how to address the non-conformances. Recently, in September 2020, the 15 companies were re-inspected to assess their effort at addressing the previously observed deficiencies only to discover further decline into non-compliance in the six companies, hence the agency was left with no option than to close down the facilities until they are ready to meet extant requirements”, she narrated.

Speaking on why the concerned companies were not exonerated, based on financial inadequacies, the NAFDAC DG averred that several companies had financial incapability and over 100 manufacturers had inspectional non-conformances for which most of them raised a plan of action and NAFDAC is working along with them to ensure they meet minimum requirements.

“However, these six manufacturers were comfortable in their old ways of doing things hoping that the drive for GMP compliance by NAFDAC will be relaxed after a while.

“This nonchalant attitude and negligence resulted in unwholesome practices, leading to their closure. All manufacturers were sensitised on the availability of Federal Government intervention funds from CBN to assist the health sector, especially for local pharma manufacturers to upgrade their facilities and meet GMP requirements.  Their participation to access the funds is through their umbrella body, PMGMAN. For the companies that remained recalcitrant, measures were taken to enforce compliance hence the shutdown”, she stated.

In a related development, the Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMGMAN) has distanced itself from the defaulting manufacturing companies, saying the health of the nation is more important than sentiments.

PMGMAN Chairman, Pharm. Fidelis Ayebae in a telephone interview with Pharmanews, said he has no sympathy for affected companies because pharmaceutical business is a serious business with lots of implications.

“NAFDAC has the right to close down any company that fails to comply with GMP guidelines. That is why I may not be sympathetic with pharma companies which fail to go by GMP rules”, he stressed.

Engage PCN, NAFDAC on Better Regulations, Superior Pharma Boss Urges Pharmacists

2

– Advises ACPN to form bulk purchasing group

A US-based Nigerian pharmacist, Ike Okeke, has urged the Pharmaceutical Society of Nigeria (PSN), Association of Community Pharmacists of Nigeria (ACPN) and all other professional bodies in the pharmaceutical sector to engage the Pharmacists Council of Nigeria (PCN) and the National Agency for Food and Drug Administration and Control (NAFDAC) for better regulations that will help reduce cost of drugs and guarantee better health for Nigerians.

Okeke, who is the managing director of Superior Pharmaceuticals Nigeria Limited gave the charge in a statement made available to Pharmanews as part of his recommendations for the Nigerian pharma industry to have a significant turnaround in the present year.

Pharm. Ike Okeke

“To have a better year 2021 that will enhance the advancement of the Nigerian pharmaceutical industry, I will encourage all the professional bodies in the pharmaceutical sector to continue to engage the regulators (PCN, NAFDAC) in crafting new rules and regulations that will better protect the citizens and lower the cost of drugs,” Okeke said.

Expressing his expectations from the Nigerian government and the regulatory bodies in the pharmaceutical sector towards a better year, Okeke posited that NAFDAC can play a vital role in stimulating the pharmaceutical sector by reviewing its tariffs to make it easier for small and medium pharma companies to survive.

He said: “The tariff charged Nigerian pharmaceutical companies for Good Manufacturing practices (GMP) desk review needs to be waived since this is a duplication of same fees paid by the manufacturers.

“Indigenous production of essential pharmaceuticals products is key to security of lives in Nigeria. The Federal Government of Nigeria (FGN), in conjunction with the local banks should offer affordable loans to pharmaceutical importers who want to go into local manufacturing. This has the capacity to create one million jobs over a 10-year period.

“NAFDAC can lower the barriers to entry of new manufacturers by relaxing some of its rules on Cardiovascular Diagnosis and Therapy (CDT) dossiers and create a department to guide and help the local manufacturers to be compliant with good manufacturing practices”, Okeke said.

The Superior Pharma boss also called on the ACPN to form a buying group that can purchase drugs in bulk from manufacturers, importers or distributors, saying such a move will help to reduce cost of purchase and the eventual unit cost of drugs, thereby increasing patronage for registered pharmacies.

His words: “ACPN has a major role to play since they are the first point of contact for most patients. They need to form a buying group that can purchase drugs from manufacturers and importers and/or distributors. The savings from such bulk purchase will then be passed to patients, which will effectively lower their cost of purchase and help to drive more patients to registered pharmacies instead of open markets and unregulated premises.

“There is also need to improve on product knowledge and disease states management so that they can capture and treat empirically those that they can treat and refer complex cases to doctors and specialists for immediate care.”

The Superior Pharma boss also seized the opportunity to reiterate the commitment of his organisation to the development of the Nigerian pharmaceutical industry, noting that the focus of Superior Pharma in 2021 is to provide medicines for life-threatening diseases.

Okeke further revealed that the company is working on newer molecules for prostate cancer, which will be introduced in 2021, adding that the company is also planning to ensure that the products are manufactured locally.

He said: “Our focus is to provide medicines for life-threatening disease like high blood pressure, diabetes, cancer and pain. We introduced Suphage (Metformin-Glymepiride), Panache (Ketorolac) for pain, Suplavat (telmisartan-amlodipine) for blood pressure and Flowel Plus (Tamsulosin-Dutasteride) for prostate enlargement.

“We are working on newer molecules for prostate cancer which we intend to introduce in 2021, like Abiraterone and other novel agents. We will transition the manufacturing of our over-the-counter (OTC) range of products like ciprofloxacin and Artemether-Lumefanthrine to local manufacturing, using local, World Health Organisation (WHO)’s preapproved plants. This will help keep our jobs in Nigeria.

“Exporting our jobs has serious security implications for everyone. We will continue to partner with ACPN and NMA to provide product knowledge and basic diagnostic skills for community pharmacists to better serve their patients and detect and prevent cases with high mortality and mobidity. Intervention of community pharmacists is critical for the overall wellbeing of our citizens.”

Gbolagade, Obideyi, Others Applaud Pharmaton 693’s Wholesale Pharmacy

1

It was a harvest of encomiums for the management of Pharmaton 693 – a cooperative society formed by a group of pharmacists with the aim of advancing each individual’s economic growth with pooled resources – following the society’s procurement and opening of its ultramodern wholesale pharmacy outlet in Egbeda, Lagos State.

The official commissioning of the Pharmaton Cooperative Wholesale Pharmacy, which took place at the company’s head office in Idimu, Lagos on 25 November 2020, had a large turnout of pharma personalities as well as members of the public.

Speaking at the occasion, Pharm. Olateju Olakiigbe, managing director, Egbeda Pharmacy, Egbeda Lagos, who was the chairman of the occasion, commended the leadership of the society for sustaining the group despite the challenges it had encountered.

The respected elder of the pharmacy profession while applauding the founding fathers of the Pharmaton 693 for conceiving such a big vision, said he was highly impressed with the level of discipline and tenacity of purpose displayed so far by the leadership in the last 27 years.

“I must commend the outgoing and the past leaderships of the society for this vision, and I would like to encourage those at the helm of affairs today not to lose focus and not to let the standard down. I encourage you not to let your guard down. Dream new dreams, and continue working with sincerity of purpose, so that the labour of the past leaders will not be in vain,” he advised.

While also speaking at the event, Pharm. Iyiola Gbolagade, chairman, PSN, Lagos State, who was represented by the vice chairman, Pharm. Babayemi Oyekunle, expressed his joy that some pharmacists 27 years ago could come together and run a viable cooperative society, noting that if other pharmacists could copy the same model, most of the challenges facing the practice of pharmacy in Nigeria would have been resolved.

Equally speaking on the pharmacy launch, Pharm. Olabanji Obideyi, chairman, Association of Community Pharmacists of Nigeria (ACPN), Lagos State chapter, shared same view with Gbolagade when he said members of Pharmaton 693 should sustain the ideals that had been guiding them since inception, adding that pharmacy practice has changed significantly,  necessitating thinking outside the box and doing things differently.

Obideyi also noted that there is need for more credible wholesalers around to be able to service the needs of the retailers, which, he said, would help reduce or eliminate patronage of unofficial or unapproved drug markets.

He added: “I want to congratulate Pharmaton 693 Cooperative and advise that more funds be pumped into the pharmacy to enable it increase its stocking level and geared towards making it a pharmaceutical hub, where virtually all the drug needs of retail community pharmacies would be met.”

Earlier, in his welcome address, the outgoing president of the cooperative, Pharm. Olusola Jaiyeoba, noted that the society which started with a few disciplined and determined individuals had steadily become an enviable group.

According to Jaiyeoba, who had served as president for two years before coming back to serve for another four years, the society had undergone tremendous transformation and had weathered several storms.

He added that together as a team, the society had attained the laudable position of being one  of the best managed community-based cooperative societies in Lagos State and had graduated from a thrift society to a Cooperative Multipurpose Society Limited (CMSL).

He added that the society transmuted to a multipurpose society in order to widen its operational base and diversify into hitherto untapped areas like asset acquisition, property development and other high interest yielding ventures.

Also speaking, a one-time president of the society, Pharm. Gafar Madehin, disclosed that Pharmaton 693 was instituted in June 1993, because the founding fathers believed that when resources are pooled together, there is a tendency to achieve more and bigger goals, adding that the society derived its name “Pharmaton 693”, from the date it was established.

In appreciation of the felicitations and goodwill messages received, Pharm. Kehinde David Oluwafemi, the new president of the cooperative, reiterated the fact that Pharmamaton Cooperative Wholesale Pharmacy is solely into wholesale distribution and has no intention of competing with the same retail outlets it ought to service in the area, adding that he is ready to improve on the successes recorded by the outgoing president and other past leaders of the society.

“In the past, we have had very strong presidents and they have laid a solid foundation, especially the last two, Pharm. Gafar Madehin and Pharm. Olusola Jaiyeoba, under whose tenure the society mutated into CMSL. So it is my hope to build on their achievements and by God’s grace, I have it as a goal to have at least five retail pharmacies and to modernise this business before leaving office.

The expansive new outlet was declared open by the Chairman of the occasion Pharm. Olateju Olakiigbe.

Also present at the ceremony were officials of the Alimosho Local Government Cooperative Society, zonal ACPN chairmen, representatives of ECOBANK, Pharm. Clement Ogunleye of Teta Pharmaceuticals Limited; members of the Lagos State Neighbourhood Safety Corps and others.

NLC Promises Insurance Cover for Health Workers

2

 

NLC Promises Insurance Cover for Health Workers
Mr Ayuba Wabba

President of the Nigerian Labour Congress (NLC), Mr Ayuba Wabba, has said that the union would work with the National Association of Nigerian Nurses and Midwives (NANNM), to facilitate the provision of insurance cover for health workers that have died of COVID-19. He made the promise during a 5-day 7th Quadrennial National Delegates Conference of NANNM, in Abuja on Tuesday. 

 

“We will work with you to know the number of those that have died to follow up on what they promised as insurance cover for COVID-19. We were told 800 health workers were infected with COVID-19.

 

“Health workers globally are entitled to hazard and inducement allowances to encourage them to work, some countries make such 50 per cent. “I am aware that in the second wave, there are so many allowances that have not been paid; I urge government to respect the understanding that we have actually reached,’’ he said.

 

Commending health workers for their selfless service, especially those, at the forefront of the fight against the pandemic, Wabba declared that good nursing care was key to the success of every COVID-19 case. He also decried the privatization of healthcare services, adding that policies are supposed to be people-oriented.

 

“Policies are meant to service the entire people. We have seen deficiency in privatisation of health care systems around the world, health is not supposed to be for profit. Health is a fundamental right of a citizen. 

 

Speaking further, he said “Some private hospitals in the country are taking advantage of COVID-19 to exploit people. We need to defend the larger population against exploitation”. 

 

The NLC President also commended NANNM for a successful change of the baton of leadership while imploring them to entrench the culture of unity and synergy amongst all members.

 

“Avoid divide and rule; nobody will like you more than yourselves, unity is necessary to achieve desired results,’’ he said. 

 

Scientists Find World’s Oldest Sperm

2

A team of palaeontologists have discovered what they believe is the world’s oldest animal sperm, frozen 100 million years ago inside a tiny crustacean in tree resin in Myanmar.

The oldest known examples of fossilised animal sperm were previously a mere 17 million years old, according to the team of experts led by Wang He of the Chinese Academy of Science in Nanjing.

The sperm was found inside an ostracod — a type of crustacean that has existed for 500 million years and can be found in many oceans today, they said in a paper published on Wednesday in the Royal Society’s Proceedings journal.

They were found in the body of a female specimen, indicating that she must have been fertilised shortly before being trapped in amber, the experts said.

Scientists Find World’s Oldest Sperm
Scientists Find World’s Oldest Sperm

The individual sperms were described as “giants”, measuring up to 4.6 times the size of the body of the male.

“This is equivalent to about 7.30 metres in a 1.70-metre human, so it requires a lot of energy to produce them,” Renate Matzke-Karasz of the Ludwig Maximilian University of Munich, co-author of the study, told AFP.

The ostracod was also a new species that the scientists have named “Myanmarcypris hui”.

‘Eureka moment’ 
Fossilised shells of ostracods are common but finding a specimen with “soft parts” is rare, the experts said.

During the Cretaceous period around 145 to 66 million years ago, the ostracods in question probably lived in the coastal waters of present-day Myanmar where they became trapped in a blob of tree resin.

The tiny creatures are less than a millimetre long but the scientists made 3-D reconstructions of them to observe them more closely, leading to what Wang described as “one of those special Eureka moments in a researcher’s life”.

As well as the sperm, the reconstructions also showed the distinctive muscular sperm pumps and penises (two of each) that male ostracods use to inseminate the females.

Most males in the animal world including humans produce tens of millions of tiny sperm cells, but ostracods are different — for them, it’s all about quality over quantity.

There are several conflicting theories about the evolutionary value of such giant sperms.

“For example, experiments have shown that in one group, a high degree of competition between males can lead to a longer sperm life, while in another group, a low degree of competition also led to a longer sperm life,” said Matzke-Karasz.

“To show that using giant sperms in reproduction is not an extinction-doomed extravagance of evolution, but a serious long-term advantage for the survival of a species, we need to know when they first appeared.”

Scientists have been researching the amber of Myanmar for decades, finding all kinds of frozen treasures including frogs, snakes and a feathered dinosaur tail.

Lagos, Canada to Collaborate on COVID-19 Response

1

The Lagos State Commissioner for Health, Prof. Akin Abayomi, says the government was exploring opportunities for mutual collaborations with Canada on COVID-19 response and other health care interventions.

Abayomi disclosed this through a series of tweets on his official Twitter account @ProfAkinAbayomi on Tuesday.

The commissioner said that the collaboration was discussed during a courtesy visit of the Acting High Commissioner of Canada, Mr Nicolas Simard, to his office.

Lagos Commences Hydroxychloroquine Clinical Trial Next Week- Commissioner
Prof. Akin Abayomi

According to him, the meeting which is at the instance of the Canadian High Commission is aimed at exploring opportunities for mutual collaborations with Lagos government and its health ministry on COVID-19 response and other healthcare interventions.

“I gave a brief overview of COVID-19 response in Lagos State; particularly on measures and strategies put in place to prevent escalation.

“I emphasised the importance of upgrading healthcare facilities, including installation of modern equipment, commissioning of Isolation centres and ramping up of COVID-19 testing capacity,” he said.

The commissioner also reiterated the state’s efforts in the areas of inclusion and partnership with the private sector.

He highlighted efforts on the adoption of Home-based Care Strategy for managing asymptomatic and mild COVID-19 cases, as well as upscaling of sources of oxygen at treatment centres.

He also elaborated on efforts of the state and wife of Gov. Bbabjide Sanwo-Olu, Ibijoke’s activities around gender-based and domestic violence, especially at the time of the pandemic.

He emphasised other emergencies including critical support needed by the state, in addressing gender-based violence and healthcare delivery services.

Abayomi, who presented the envoy with the ministry’s 2021 diary, expressed appreciation for the visit and readiness to collaborate on effective health delivery for a greater Lagos.

(NAN)

We Start from different Lanes

0

“Pay now or pay later. Either way you’re going to pay.”

– John C. Maxwell

I wish you a happy and productive year 2021.

The Olympics athlete is expected to stay on his lane if he wants to win the race. He must also run the race like someone who is prepared to win. The race waits for him. He must run his race!  Winning in the race is a function of staying in the track, on your lane and standing out in performance! The best wins!

Life is like a marathon race. Life is also a journey. The main thing is to commence the journey, irrespective of your beginning point. Whether the individual begins now or later, the journey will still be there waiting for him or her.

Starting point shouldn’t determine end point

The truth is that the journey of life is not transferable. Everyone is embarking on his or her own journey. Keep moving forward! Take yourself to higher heights. Don’t stop doing your best. Plan and implement. Think smart. Work hard. Build capabilities. Build capacity. Do more, better.

Brian Tracy- endorsed speaker and training consultant
George O. Emetuche

Experience has taught me that people begin the journey of life at different points. Some people begin at point zero. Some start theirs at minus one. Some start at plus one, while others start at plus five.

Let me explain. The people who begin the journey at point zero are folks who start on a clean slate. They start at break-even point. They are owing no one and no one is owing them. They embark on their journeys without having to pay anyone for previous debts. They only need to work hard and be focused on chasing their goals. If they do this intelligently and diligently, they will succeed.

The second group are the ones that start at minus one. This group starts from point of deficit! These are folks who are owing before they begin the journey. Some of the people here borrowed money to go to school. Some of them had tough experiences when they were learning trades or skills that will launch them in the journey.  The individuals in this group are folks coming from humble beginnings. They are people who know the real meaning of poverty; they have shaken hands with poverty in the past!

Many people belong to this group. And the truth is that a lot of folks in this category become successful because they fight with everything they have – to come out of their disadvantaged situations. Individuals in this category often score high on grit scale. This makes a lot of difference.  A study in the US reported by Brian Tracy shows that 87 per cent of self-made millionaires started at the lowest level. In fact, at this level, it’s either you fight and live, or stay put and die!

A lot of us started here.  Where are you at the moment? Where are you starting from this year? Develop the right mindset and move on.

The third group are folks who start at plus one. Individuals here start from a somewhat advantageous position. Players here were sponsored to school – to any level they wished. If they desired to start businesses, they had access to necessary support. People in this category also have contacts that will make the journey a little easier.  If you find yourself in this category, do more to soar higher.

 

The last stage are folks who start at plus five. Individuals in this group are the ones we describe as “born with silver spoon”; in fact, I think “golden spoon” is more appropriate! The guys here know the meaning of affluence. They started from very strong positions. They go to Ivy League schools. Their families have big businesses and estates.  Folks in this category are wealthy. The children of men and women here are expected to take the family wealth to the next level. If you are in this category, you don’t have any excuse. You have what it takes to keep expanding value. You must keep doing your best in order to continue to give value to the society.

 

Different lanes, same destination

If you go through the four categories we explored, you will notice that everyone starts from different points, but the denominator is the destination. The definition of destination is the same. Everyone wants to succeed.  The aim of the sprinter in a race is to win gold. Winning is the destination.

No matter the point from which you started your life’s journey; no matter the advantageous or disadvantageous position, the goal is your destination. Your destination is to succeed. Your goal is to tell a beautiful story about how you reached your destination. Excuses don’t make champions. Where you began the journey of life is a means to an end, and not necessarily an end in itself. People succeed out of nothing. People fail out of nothing. Folks succeed in affluence; folks fail in the midst of abundance! This is life. Life is neutral.

Note this: The main element that changes the narrative is the man in the mirror and that man is the individual embarking on the journey. We can change the narrative if we believe and work it. We are called to succeed.  Succeed from your lane. Go and win this year!

 

George O. Emetuche, CES, MNIMN, is a Brian Tracy endorsed bestselling author, accredited training consultant, life and business coach, sales and marketing expert. Please reach us for cutting edge training of your team.  Buy books by George O. Emetuche from nearest malls or bookshops. You can also get autographed copies from the author. The books are:

The Selling Champion, The Art of Selling, The 25 Unbreakable Laws of Sales, Everything Is Possible, The 11 Irrefutable Principles of Success, Be Inspired, Succeeding With Your Spouse.

www.hesellingchampionconsulting.com.

We Have Improved ACPN Lagos, Despite Constraints – Obideyi

1

As the newly elected executives of the Association of Community Pharmacists of Nigeria (ACPN), Lagos State Chapter, prepare to take over the reins of service, the outgoing chairman of the association, Pharm. Olabanji Benedict Obideyi, has urged them to continue with the dreams and aspirations of the forefathers of the association. Speaking in an exclusive interview with Pharmanews recently, Obideyi reminisces on the last three years of his administration, highlighting the successes and challenges. Excerpts:

Pharm. Olabanji Benedict Obideyi

How has it been as the chairman of the largest ACPN chapter in Nigeria?

It’s been interesting and quite challenging. For me, actually, it’s been a rare opportunity to serve the association and to also learn, because leadership is not something one learns in school. In the course of working, I have been able to learn a lot and gather experiences. So, for me, it’s been a worthwhile experience, especially knowing that I was contributing to the development of the association.

What were your motivations for taking up the exalted office in the first place?

Attending to the needs of the association, improving the standard of the association and attending to the yearning of our members, as well as contributing my quota to the progress of the association were part of my motivations for taking up the challenge to be the chairman. I think to a certain extent, I have been able to achieve some of these – maybe not up to the extent one would have wished due to some challenges, including the pandemic which crippled so many of our regular programmes and made our performance to be a bit low this year.

How many of your goals were you able to satisfactorily achieve?

I have been a cabinet member of the ACPN since 2012 when I became the secretary, after which I became the vice chairman. I later emerged the chairman about three years ago. So, I had witnessed about two administrations before mine. I had seen a lot – the challenges, the achievements and the lapses. Consequently, when I became the chairman, it didn’t take me much time before I get down to business.

At inception, we had a lot of goals and we were able to do a lot during the first and second years, except for this year when we had setbacks as a result of the pandemic. As I said earlier, my major goal was to protect the interest of the members and attend to their aspirations, which we were able to do. We instituted a policy that made it easy for members to acquire the pharmacy emblem and we enforced the monitoring, which to a certain extent addressed the issue of fake emblems.

We also, to a great extent, addressed the issue of harassment of our members by the law enforcement agents and regulators, especially during the codeine saga. Also, at the peak of COVID-19, as a responsible association, we contributed our quota to the containment of the pandemic by donating hand sanitizers and other items to all the local governments and local council development areas in the state.

Recently also, we conceptualised the idea of having a cooperative venture and government has given us the approval to go ahead.

Aside from COVID-19, were there other challenges that affected your administration?

None, really, as our members have been cooperating and have fulfilled all their membership obligations by paying necessary dues and other obligations. However, we could say that there were challenges in terms of funds because, as a result of the pandemic, so many of our programmes were unable to hold. Consequently, revenue generation dropped drastically this year. Our members of the executive have been working as a team and the general members too have been cooperating with us. So I would say it has been a peaceful house in the last three years.

There were lots of agitations and internal wrangling when you were coming on board. What is the situation now?

Yes, there were lots of agitations about our laws not being in tandem with today’s practice. So, when we came in, we sat over it and the AGM in 2018 mandated us to review those laws and today we have bye-laws that have addressed all the issues that led to that pre-election agitations.

Looking back, would say you are fulfilled being the chairman, ACPN-Lagos, for the last three years?

No leader, whether in an association or government, can confidently say he or she has been able to fulfil all of his or her aspirations, but I am fulfilled because I have done my quota. When a leader is elected or selected, they always have certain goals that they want to achieve, but at the end of the day – either due to time factor or other factors – they may not be able to achieve everything.

I won’t say we have fulfilled all our aspirations but, to a certain extent, without doing self-praising, we have not done badly. Within the short time, we were able to successfully amend our bye-laws; we visited all our zones; we set up a forum for timely information about regulatory and pricing for members; we worked together with donor agencies to build the capacity of members; we created an enabling environment for acquisition of emblems; we continually updated the database of members; we donated hand sanitizers to all the 57 local governments and local councils in the state; we facilitated the formation and take-off of ACPN Lagos cooperative society; and so many others.

Any regrets?

We have no regrets, really, but some of our plans that could not be achieved due to certain constraints include delivery of an  e-secretariat to the association, and resolving the problem of exclusion of our members from the Lagos State Health Insurance Scheme. This second issue was occasioned by our not being able to see the Commissioner for Health, Prof. Akin Abayomi, due to COVID-19 pandemic. But it is our hope that the incoming administration would work on achieving these among other plans they may be having in minds to execute.

What is your advice to the incoming administration?

To the glory of God, we have done our bit, so I would want the incoming administration to continue from where we stopped, and take the association to the next level. I would want them to continue in unity and oneness and carry everybody along.

Our Joy at Foundation Pharma is Bringing Relief to Patients – Izunwa

1

Pharm. Kennedy Chukwuemeka Izunwa is a Fellow of the Pharmaceutical Society of Nigeria (PSN) and managing director of Foundation Pharmacy and Stores Limited, based in Lagos. In this special interview as chief executive officer (CEO) of the month, Izunwa, who is also the technical director of the Association of Pharmaceutical Importers of Nigeria (APIN) speaks on why access to medicines is a fundamental human right and how his company is working to ensure that the delicate balance between affordability and quality of their products is maintained at all times in the drug distribution chain. He also airs his views on other pertinent issues relating to drug importation, local drug production and so on.  Excerpts:

Tell us about Foundation Pharma – its vision and mission in the Nigerian pharmaceutical landscape.

Foundation Pharma Limited is a duly registered pharmaceutical company in Nigeria with interest in importation and distribution of quality pharmaceutical products to serve the Nigerian population. Our mission is to make sure that quality pharmaceutical products are made available to majority of the Nigerian people, if not all. Helping to create greater access to quality medicines at affordable prices is a very important part of our mission as a responsible corporate entity.

Nigeria, as a developing country, has a myriad of tropical diseases and other healthcare issues plaguing its population. What disease area of therapeutic segments are you currently focusing on with a view to bringing lasting relief to the Nigerian populace?

Currently, we have quite a good range of products with emphasis on the cardiovascular area. The focus on the area of cardiovascular drugs is informed by the need to help bring quality relief to patients of cardiovascular illnesses at an affordable cost.

If you check what is happening in the country today and you take a statistics of patients with hypertension or related ailments, such as diabetes, heart disease and so on, you will see that there is so much to do. For that reason, we try to get top range pharmaceutical products that will assist our doctors in handling the challenges posed by these disease conditions. We also have very unique products for the treatment of pains associated with inflammation.

Our range is quite wide. So, we have products for the management of pain, cardiovascular diseases and other conditions. We also have a multivitamin product that is very popular in the market.

Cardiovascular diseases are mostly lifelong conditions that have to be managed with drugs taken at recommended intervals over a long period of the patient’s life. Here in Nigeria, there is the challenge of the cost and affordability of these drugs. As a stakeholder in the pharmaceutical intervention to manage these conditions, what are you doing to ensure that your drugs are not only of top quality but also affordable?

Yes, top quality and affordability is a delicate balance that has to be maintained. Top quality is very important. The issue of affordability is also very important because no matter how good the product is, if it’s not affordable, there is a problem, as people would not be able to access it. So we try as much as possible to make our products affordable, knowing very well that pharmacy practice for us is essential, not only as a business but a humanitarian service.

For us at Foundation Pharma, our joy is not essentially in making huge profits but in the number of persons we are able to give relief from disease conditions or put smile on their faces. To that extent, we derive our joy from the number of persons that are able to derive maximum benefit and relief from our products. Money may not come immediately but we believe that if we continue to do the right thing, then money will come.

What are your thoughts about the COVID-19 pandemic and how it has affected businesses, especially in Nigeria? Do you agree that it has been a period of boom for pharmaceutical and allied businesses?

Diseases or pandemics cannot be a blessing to anyone. To me, the pandemic is a huge disaster to mankind. It is a huge disaster to the economy, and pharmaceutical companies operate within the economy. Pharmaceutical companies will not be happy that people are suffering from sicknesses because they are selling immune boosters, Vitamin C, multivitamins and all other drugs. No, the emphasis should be more on advocacy than pharmaceutical interventions. What do you gain when you make so much profit from pharmaceutical interventions when you are not even exempted from getting the pandemic that other people are contracting and dying of?

As the technical director of the Association of Pharmaceutical Importers of Nigeria (APIN), how can Nigeria attain a healthy balance between local drug production and importation? Is banning importation of a wide range of drugs a solution to issues militating against local drug manufacturing?

People who advocate outright ban on imported products are being rather unrealistic. As an experienced pharmacist, my own position has always been that a holistic approach should be put on ground where you ramp-up factors that will encourage local production.

No nation is completely self–sufficient in local drug production. If you are into drug importation, you know you should be aiming at local drug production but you don’t just do that. You need to adopt a well-calculated approach. You start by putting infrastructures in place and start producing at least the non-active pharmaceutical components, such as pharmaceutical grade starch and others in sufficient quantity locally. These are areas in which we have strong capacity. We can get sufficient binders locally. From there, you now move to the production of petrochemical products to see if we can get raw materials.

As we are scaling up our local inputs, we begin scaling down on importation so that there will be a seamless transition from importation to local production. Gradually, you turn the table around but it has to be a careful and well-calculated approach with a reasonable timeline. It is not something you do by fiat. If you do it by fiat, you cut people’s access to essential medicines and at the end of the day, the patients will suffer.

So at every point in time, we must look at the accessibility of medicines to the patients’ population whose wellbeing is paramount in this whole discussion. Access to medicine is a fundamental human right. So it’s a crime to inhibit access to medicines to people that need them.

At the same time, an economy that depends fully on importation will never grow. Nigeria is endowed with rich natural and human resources. We can make good use of these resources from God and gradually grow them to turn the table around from an importing country to a country with sufficiency in drug production. We always believe that this is the path to follow and not by fiat. If you do it by fiat, you will hurt the drugs distribution chain and the patients will suffer.

There are quite a litany of issues facing the pharmaceutical industry in Nigeria, ranging from infrastructural problems to power issues, high cost of foreign exchange and the rest. Which of these issues do you think should be tackled mainly by government?

All of them are very serious issues. If you talk about infrastructure – if I tell you how long it takes to get a container out of the wharf, you would be surprised. It takes a lot of time because of the problem of access to the ports. The longer it takes, the more expensive it becomes to get the container out and this cost is eventually passed to the end users of the products.

What about power? There is now way you can successfully run a pharmaceutical company without producing your own electricity. The cost of running your generator is sometimes twice the cost of every other thing. Then we talk about the high cost of foreign exchange. That one has has a direct impact because it’s like garbage in, garbage out. The high cost of foreign exchange affects even local manufacturers because they import raw materials, machineries and some other inputs also. Even water that some people claim is sourced locally, is treated with materials and machineries that are also imported. Again, all the active pharmaceutical inputs are also.

The local manufacturer who imports everything he needs to produce locally is affected as much as the pharmaceutical importer by the high cost of foreign exchange. This also affects costs of drugs to the patients and their access to the drugs. Therefore, I will advocate for a special window for pharmaceutical companies especially those who are bringing in essential medicines. Government should help create a special window, where they will be able to access foreign exchange at a concessionary rate. That, to me, will impact positively on the lives of Nigerians

Do you have plans for local drugs production?

There is already a solid arrangement waiting to manifest. It is a given. I have always said that every pharmaceutical importer is a local manufacturer in disguise. When you start importing, you should be encouraged to bring in your foreign partners to set up local plants in Nigeria.

Pharmaceutical importation in Nigeria is not pure importation per se; it’s contract manufacturing because what happens is that the brands belong to us but you outsource the manufacturing. The same way you would have outsourced to local plants but because of infrastructural deficits.

While you are importing, you will need to work towards collaborating with your foreign partners to try and set up even if it’s a small plant to handle some productions locally. That is the way to go. Local drug production is good but it has to be done systematically and orderly. While you are importing, always have it in mind to make efforts towards producing locally because that is the way to go.

What’s your advice to the younger generation of pharmacists on how to take the pharmacy profession to greater heights?

I will always advise the younger ones to learn from the older colleagues. Experience is never purchased in the market. I even wish there is a better organised scheme in which the older ones can mentor directly the younger ones in terms of education, practice, ethics and so on. Mentorship is good if it’s done in such a way that somebody who has knowledge, experience, expertise and is of a very dependable character mentors a younger person.

Another thing I want pharmacists to remember is that the life of a patient is affected by our practice. Therefore, we have to be disciplined and careful without too much emphasis on money or monetary profits.

What do you Understand by Passive Diffusion?

3

What kind of substances can’t permeate membranes by passive diffusion?

a) Lipid-soluble

b) Non-ionized substances

c) Hydrophobic substances

d) Hydrophilic substances

Experts Link Anxiety with Smoking

0

Ever since this pandemic started, many health experts all over the world have more reasons to think back to the link between smoking and anxiety: They came up with questions like, does smoking cause anxiety? Or does anxiety cause people to smoke?

Just like every other aspects of addiction and mental health, they don’t have a specific conclusions.

Brian Hitsman, an associate professor of preventive medicine at Northwestern University Feinberg School of Medicine in Chicago said he thinks he and his colleagues have generated more questions on the subject of smoking and anxiety than they have answered.

The professor said anxiety and smoking are the most popular mental health issues in the United State of America which affects 15 to 19 per cent of the adult population and surrounding everything from phobias and panic attacks to intense fear of social situations and worries.

The latest data released in November from the Centres for Disease Control and Prevention showed 45 per cent of people with severe anxiety use tobacco. Even for those with mild anxiety, 30 per cent use tobacco. Yet for those who report little to no anxiety, only 18 per cent use tobacco.

Another research in Current Psychiatry Report also shows higher rates of anxiety disorders among smokers than the general population.

A man seen smoking

Lorra Garey, the study’s lead author, said alcohol and substance abuse could be clouding the true connection. Another complicating factor is the two-way relationship between smoking and anxiety.

“It’s this perpetual loop feeding into itself. You have anxiety contributing to smoking … and then you have people becoming addicted to nicotine and experiencing acute withdrawal with symptoms that mimic anxiety,” said Garey, a research assistant professor at the University of Houston.

“These things are so interrelated it’s hard to tease apart,” she said. “Ultimately, we need more rigorous research to really track the different factors over time to fully understand them.”

Another problem, Hitsman said, is smokers often mistakenly think having a cigarette will tamp down their anxiety.

“It’s in their head that smoking is an effective way to manage their emotional distress, but it’s probably only making them feel better because it’s helping manage their nicotine withdrawal,” he said. “Smoking actually increases your heart rate and causes changes in the body that are opposite of relaxation.”

In fact, smoking wreaks havoc on the entire cardiovascular system, releasing chemicals that damage and clog arteries, which can lead to a heart attack or stroke.

Whether tobacco use and anxiety rates have been affected by the COVID-19 pandemic is difficult to pinpoint. But Garey suspects they’re rising.

“So many factors that contribute to anxiety—financial burden, child care issues—are making it worse. And there’s also a concern about a greater severity of smoking, and people who’ve quit restarting,” she said.

Quitting smoking can be incredibly difficult for anyone, largely because of the presence of nicotine, a highly addictive drug the U.S. surgeon general once likened to heroin and cocaine. During the pandemic, people struggling with nicotine addiction might find it harder than usual to set up doctor’s appointments or counseling sessions.

Explaining wide varieties of methods that can help smokers, Garey said exercising daily, prescription methods and replacing nicotine products with gum and patches can help the battles that come with nicotine withdrawal.

She added that smokers who have anxiety benefit more from taking exercise, doing yoga and practicing belly breathing exercise.

“Smoking is such an automatic, time-consuming thing, so it can be so helpful to take a break, focus on the moment, and replace smoking with something healthy that you really enjoy, she advised”

 

Developing a Flux Culture That Supports Growth in 2021

2

There are three keys to growth as an individual or an organisation: Strategy, leadership and culture. Having the right strategy in place will save you time, efforts and resources. Possessing the right leadership mindset to take responsibility for your results will fast track your success and greatness. However, you must also develop the culture required for growth and transformation because strategy and leadership are not enough. Peter Drucker brilliantly opined, “Culture eats strategy for breakfast every day.”

Year 2020 has clearly revealed how uncertain our world is, how well-planned strategy can become quickly outdated. Year 2021, provides a new opportunity to think and act differently. Most important, the new year comes with new opportunities to do things differently in order to achieve better results.

By the way, what is culture? Culture is a set of beliefs and behaviours that define how work gets done, what is appropriate and what is not. Culture is how you do things as an organisation.  Beliefs are a set of assumptions people bring to work every day and that manifests throughout the company as “things we hold to be true.”

80 hearty cheers to an Icon: Sir Ifeanyi Atueyi
Pharm. Sesan Kareem

Behaviours are the things people do every day to get work done: the actions that we take and the words we say. An individual’s behaviour is a reflection of their belief. Therefore, to transform the way people behave in your organisation and the level of results they achieve, you must first disrupt their belief system. Mandating a new behaviour like openness makes little impact unless it reflects a fundamental shift in the underlying beliefs.

There are two types of culture – stuck culture and flux culture. A stuck culture is one that is stuck in the past with the beliefs, “This is the way we’ve always done it,” “Do not share information with others” and “What works today will work in the future.” In a stuck culture, everyone follows the chain of command; there is no room for creativity and people in leadership position can’t stand being challenged.

On the flip side, a flux culture builds a foundation of trust and safety, giving people the audacity to push the limits of norms, disrupt things and radically transform how work gets done. A flux culture thrives on the beliefs that, “there is always a better way,” “information is quickly shared except on a need-to-keep-secret basis”, and “what works today won’t in the future, unless it is improved.”

In my study, I have found three beliefs that support flux culture in different organisations, regardless of the industry or size. They are openness, agency and action. Organisations like McKinsey, ING Bank Netherlands, Nokia, Amazon, Alibaba, GT Bank, Google, Southwest Airlines and Microsoft are examples of companies that have developed flux cultures that support innovation, disruption and transformation.

First, openness is the availability of information for decision-making in the organisation. The more information that is available and the faster it flows bottom up and top down, the more likely it is that the organisation can make use of it to drive growth and decision-making.

You must commit to sharing information freely within the organisation. Publicly-recognised top performers encourage average performers and inform poor performers their stand. Create platforms within the organisation to share information quickly. Always ask for feedbacks on processes and policies. However, the only information that should not be shared are on a need-to-keep-secret basis like legal proceedings, intellectual property or salary information.

Second, agency is giving employees the enabling environment to take ownership, as well as the authority to make some decisions within their own sphere of influence. Organisations that give their employees the capacity to act independently and make their own choices help them to see themselves as owners and partners-in-progress of the transformation journey.

By the way, agency is not the same as empowerment, which is the power that comes from leaders at the top to employees at the bottom. Agency is a two-way street: power comes with responsibility and accountability. Companies that give their employees agency over decisions make this understanding explicit: if you get to make a decision, you will be accountable for it. Simply put, agency is more than empowerment.

Third, a bias for action is the most significant advantage of flux culture over stuck culture. Flux culture speeds actively toward change because of the opportunities and possibilities for growth it represents. Flux culture prefers action over inaction, taking risks rather than seeking certainty, climbing new mountains instead of staying in the same place. A bias for action empowers organisations to constantly position themselves for new growth.

As a business leader, you can start changing your culture by identifying the beliefs that hold your team back and develop the system to not act on those beliefs anymore. The system to change includes structure, process, rituals, symbols and stories that form the soul, backbone and lifeblood of your organisation.

To make year 2021 a productive and profitable year for your organisation you must adopt new beliefs and behaviours that support growth and disruptive transformation.

 

ACTION PLAN: How can you work on yourself to develop a new belief system that supports growth? How can you invest in your employees to develop a new culture that supports disruptive transformation?

AFFIRMATION: I have what it takes to make year 2021 a profitable year. I am blessed and highly favoured.

 

Sesan Kareem helps business leaders and organisations instils within them, not just the belief system to succeed and the motivation to excel, but also the actionable strategies to grow and thrive in our ever-changing world.

NAFDAC and the GMP Mandate

1

The recent decision of the National Agency for Food and Drug Administration and Control (NAFDAC) to shut down six local pharmaceutical companies for non-compliance with its Good Manufacturing Practice (GMP) requirements is a step in the  right direction and deserves the commendation of all stakeholders in the industry.  NAFDAC’s Director General, Professor Mojisola Adeyeye, while announcing the closure in a statement made available to pressmen, said that the agency’s decision was in furtherance of its zero tolerance for circulation of substandard and falsified (SF) medicines in the country.

Adeyeye added, very importantly, that NAFDAC did all within its powers to avoid such a drastic measure by not only issuing appropriate notifications to the affected companies on the need to upgrade their facilities and production processes in line with extant requirements, but also demonstrating its readiness to help them achieve the objective.  Sadly, as the NAFDAC DG revealed, the companies rebuffed the agency’s gestures, with the belief that it was all huff and puff that would sooner or later fizzle out. As they have realised however, NAFDAC seems bent on keeping to its cardinal mandate of ensuring that both locally manufactured and imported pharmaceutical products consistently meet required product specifications for quality, safety and efficacy.

In the first place, it indeed beggars belief that any company manufacturing products as sensitive as medicines and other pharmaceuticals would wait to be hounded by NAFDAC before seeking to comply with its GMP stipulations. For the avoidance of doubt, GMP, as explained by NAFDAC and the World Health Organisation, is that part of quality assurance which ensures that pharmaceutical products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by their marketing authorisations. The essence is to diminish the risks inherent in any pharmaceutical production and ensure that patients and the general populace are not placed at risk.

These laudable objectives of the GMP cannot and must not be compromised for any reason. Otherwise, the Nigerian health sector may relapse to the infamous pre-Akunyili era when fake and substandard drugs flooded the market and took a monstrous toll on the health and lives of many Nigerians.

While some may argue that the clampdown on the defaulting companies negates the nation’s pursuit of self-sufficiency in the production and provision of medicines to the generality of its citizens, it must be emphasised that safeguarding the health of the citizens is much more important than proliferation of local manufacturing companies. Moreover, it is in ensuring that quality standards are established and complied with that the citizens will have more confidence in locally manufactured products and other countries will associate Nigerian pharmaceutical products with quality. Therefore, while NAFDAC and other regulatory agencies are equally expected to be business-facilitators, it should be noted that the best way to facilitate and promote a business or an industry is make it known for consistent commitment to quality.

It is equally worth mentioning that NAFDAC has shown that its ongoing activities towards pharmaceutical manufacturing companies are not driven by sadistic inclinations but the desire to guide them on the path of total transformation, excellence and prestige. Indeed, as the agency disclosed, over 100 inspected facilities were found to be guilty of non-conformance with the GMP requirements. Yet, rather than wielding its sword of Damocles against them, it simply warned and encouraged them to come up with a plan of action, which the majority complied with. Moreover, the agency went ahead to sensitise manufacturers on the availability of Federal Government intervention funds from CBN to assist the health sector especially for local pharmaceutical manufacturers to upgrade their facilities and meet GMP requirements. These are highly progressive and commendable gestures.

We urge NAFDAC not to relent in its renewed campaign to rid the country of unwholesome medicines. It must vigilantly and determinedly continue with its surveillance on the activities of drug manufacturing companies and ensure that only medicines that are safe, efficacious and of good quality are accessible to Nigerians.  The agency must also continue to assist the local manufacturers in becoming paragons of excellence. Especially with Nigeria as the hub of pharmaceutical manufacturing in the West African sub-region, the pharmaceutical market must be thoroughly regulated and quality assurance activities must be consistently carried out to ensure that only the best are allowed to circulate.

We call on pharmaceutical manufacturing companies in the country to cooperate with NAFDAC in its drive to enforce quality compliance; they will be the ultimate beneficiary as Nigerians and foreigners become much more comfortable with buying made-in-Nigeria medicines. With the supportive posture of NAFDAC and the funds available from the CBN, both the six companies that have been temporarily shut down and others still in business can all join hands together with the agency to ensure that the Nigerian pharmaceutical industry is globally reputed for its unflinching commitment to good manufacturing practice.

Red Cross Doubles Front-Line Disaster Relief Funding

1

The Red Cross announced on Monday it was more than doubling disaster relief money for front-line responders, in a change to how it reacts to climate-related humanitarian crises.

The International Federation of Red Cross and Red Crescent Societies, the world’s largest humanitarian network, said the expansion was part of an attempt to adapt emergency responses to the increased crisis caseload caused by climate change.

IFRC secretary general Jagan Chapagain said that in the past three decades the number of climate and weather-related disasters had increased by nearly 35 per cent.

“Over the past decade alone, 83 per cent of all disasters were caused by extreme weather and climate-related events that killed 410,000 people and affected 1.7 billion,” he said in a statement.

“It is unrealistic and irresponsible to expect that the needs created by these events have been or will be met by international actors. Instead, we need to do a better job of supporting the efforts of local responders.”

The IFRC believes its Disaster Relief Emergency Fund is the most efficient way of channelling money to front-line responders because the Red Cross and Red Crescent societies that receive the funds are already embedded in the communities they assist.

The DREF was set up in 1985 to provide immediate financial support to national Red Cross and Red Crescent societies, enabling them to operate as first responders after a disaster.

It has supported more than 200 million people since then, said the Geneva-based IFRC.

Recently, an average of 30 million Swiss francs ($34 million, 28 million euros) has been channelled through the fund annually.

The IFRC plans to work with donors to double this in 2021, with a view to growing it to 100 million Swiss francs a year by 2025.

The federation is also expanding its forecast-based action plan to anticipate and mitigate disasters, releasing funding early for swift interventions based on risk.

The approach was used six times in 2020, notably in Bangladesh, Ecuador, Mongolia and Mozambique, for example by snap evacuations or strengthening houses.

“For years, we have warned that the world’s reactive approach to disaster management was inadequate,” said Chapagain.

(AFP)

COVID: UAE Records 3,579 New Cases, 9 Deaths

3

The Ministry of Health and Prevention (MoHAP) in the United Arab Emirate has disclosed that it has recorded 3,579 new coronavirus cases, bringing the total number to 277,955. It also announced 9 deaths as a result of complications bringing the total number of deaths to 792.

MoHAP also noted that an additional 4,166 individuals had fully recovered from COVID-19, bringing the total number of recoveries to 251,484. MoHAP announced 3,579 new coronavirus cases, bringing the total number of recorded cases in the UAE to 277,955.

As part of its intensified testing campaign, the ministry has announced that it conducted 179,117 additional COVID-19 tests over the past 24 hours, using state-of-the-art medical testing equipment.

It also added that an additional 4,166 individuals had fully recovered from COVID-19, bringing the total number of recoveries to 251,484.

According to the ministry, there is the urgent need to continue expanding the scope of testing nationwide to facilitate the early detection of coronavirus cases and carry out the necessary treatment.

In order to ensure strict adherence to its intensified testing campaign, the ministry has said it conducted 179,117 additional COVID-19 tests in the last 24 hours, deploying the best testing equipment.

Confirmed reports indicate that the infected individuals are persons of different nationalities and are in a stable condition, receiving the necessary care. The ministry expressed its sincere condolences to the family of the deceased and wished COVID-19 patients a speedy and full recovery. It also called on all members of the society to cooperate with health authorities, adhere to the instructions and observe physical distancing to ensure the health and safety of all.

 

What do you understand by babiturate action?

4

Indicate the mechanism of barbiturate action (at hypnotic doses):

a) Increasing the duration of the GABA-gated Cl- channel openings

b) Directly activating the chloride channels

c) Increasing the frequency of Cl- channel opening events

d) All of the above